FINAL PROGRAM www.essm.org 10th Congress of the European ...

10th Congress ofthe European Societyfor Sexual MedicineHosted by thePortuguese Society ofAndrology25 - 28 November 2007Lisboa Congress CenterLisbon • PortugalFINAL PROGRAMwww.essm.org

Enhancing RelationshipsRenewing LoveScience For A Better LifeOver 150 million men around the world sufferfrom erectile dysfunction (ED), an afflictionthat impacts the sexual relationships of millionsof couples. In about 70 percent of cases,ED stems from physical causes.There are a number of treatments availableto address ED. Bayer HealthCare encouragesthose affected with ED to see theirdoctor to discuss ways to restore confidenceand to help rekindle the love lives of couplesaround the world. www.bayer.com

Table of contentsPageWelcome to the 10th ESSM Congress ...................... 2About ESSM ............................................................... 4ESSM Committees ..................................................... 5ESSM Award Winners ............................................... 6Acknowledgements .................................................. 6Lisboa Congress Center - Floor Plan.......................... 7General InformationCongress Registration Counter ................................... 8Congress Registration Fees ......................................... 8Congress Language ................................................... 9Publication of Proceedings.......................................... 9Congress Documentation ........................................... 9Congress Information SystemCO CONGRESS ONLINE ® ............................................. 9Speakers Centre and Lounge ..................................... 9ESSM Membership Issues ........................................... 9Name Badges.............................................................. 9Technical Exhibition .................................................. 10Poster Exhibition....................................................... 10Poster CD ROM ........................................................ 10Internet Centre......................................................... 10Wireless Lan.............................................................. 10Press......................................................................... 10Electronic Information Boards.................................... 10Coffee and Lunch Breaks ......................................... 10Restaurants .............................................................. 10Cloakroom ............................................................... 11Bank ........................................................................ 11Lost and Found ........................................................ 11PageMobile Phones ........................................................... 11Program Changes........................................................ 11Insurance ................................................................... 11Car Park ..................................................................... 11Taxis ........................................................................... 11Currency .................................................................... 11Electricity ................................................................... 11How to get to the Lisboa Congress Center.................. 12Public Transportation Pass .......................................... 12Portugal...................................................................... 13City of Lisbon.............................................................. 13Travel to Lisbon .......................................................... 13Climate....................................................................... 13Supporting Program .................................................. 14Introduction to the Scientific ProgramFormat Descriptions ................................................... 16CME Continuing Medical Education............................ 17ESSM Grants and Awards............................................ 17Opening Ceremony ................................................... 17Program Schedule ...................................................... 18Scientific ProgramSunday, 25 November 2007........................................ 22Monday, 26 November 2007....................................... 23Tuesday, 27 November 2007....................................... 30Wednesday, 28 November 2007.................................. 37Poster Presentations .................................................. 40List of Exhibitors and Map ........................................ 52List of Chairpersons and Presenters..............................53Congress and Exhibition OfficeCPO HANSER SERVICEHanser & Co GmbHZum Ehrenhain 3422885 Barsbüttel • GermanyTelephone: +49 40 670 88 20Fax: +49 40 670 32 83E-Mail: essm@cpo-hanser.deScientific SecretariatPetter HedlundDepartment of Clinical PharmacologyLund University Hospital22 185 Lund • SwedenTelephone: +46-46-175 635Telefax: +46-46-211 19 87E-Mail: petter.hedlund@med.lu.seESSM SecretariatLavinia Riccic/o AIM CONGRESS - AIM GroupVia Ripamonti 12920141 Milan • ItalyCongress VenueLisboa Congress CenterPraca das Industrias1300-307 Lisbon • PortugalTelephone: +39-025-6601 289Telefax: +39-027-0048 577E-Mail: admin@essm.org

Welcome addressesDear Colleagues,It is a great honour and a supreme pleasure to welcome you to Lisbon, the venue ofthe 10th ESSM Congress 2007.At the moment Lisbon gets ready to welcome the political leaders of the EU, who willsign the document which will be known in the European History as the Lisbon Treaty.Also more than two thousand physicians and scientists who will participate in the10th Annual Meeting of the European Society for Sexual Medicine will be expected inLisbon. We all hope that both events will be markers for the future.N. Monteiro PereiraAll over the world Sexual Medicine explodes as an exciting branch of medical knowledge.Being an area that contains the medical aspects of sexual affairs and the sexualaspects of medical affairs, Sexual Medicine congregates an increasing number ofspecialists.At the congress you will have the opportunity to experience a stimulating scientificprogram with up-to-date science and research findings in the wide field of SexualMedicine.And what to explore in Lisbon? Lisbon is a lively and attractive city with its own culture,history, architecture as well as its music which are omnipresent. Its open inhabitantsunderline the nice and friendly south European atmosphere of Lisbon. You willalways find interesting spots to discover during day and night time. Therefore, we arevery pleased to have Lisbon as a special place for the Annual Meeting of the EuropeanSociety for Sexual Medicine.Please take this opportunity to make new contacts and gain new scientific knowledgeas well as unforgettable memories.I am sure you will enjoy this 10th ESSM Congress.Professor Nuno Monteiro Pereira, MD, PhDChair of the 10th ESSM Congress

About ESSMESSM PresidentProf. Francesco Montorsi, MDDepartment of UrologyUniversita’ Vita Salute San RaffaeleVia Olgettina 6020132 Milan, ItalyTelephone: +39-02-2643 7286Telefax: +39-02-2643 7298E-Mail: montorsi.francesco@hsr.itChairperson of the10th ESSM Congress 2007Prof. Nuno Monteiro Pereira, MD, PhDDepartment of Health SciencesUniversidade LusófonaCampo Grande, 3761749-024 Lisbon, PortugalTelephone: +351- 217515577Telefax: +351- 217515598E-Mail: n.pereira@ulusofona.ptESSM Presidents1993 - 1997 Gorm Wagner, Denmark1997 - 1999 Inigo Saenz de Tejada, Spain1999 - 2001 John Pryor, UK2001 - 2004 Dimitrios Hatzichristou, Greece2004 - 2007 Francesco Montorsi, ItalyESSM CongressVenues and Chairman1995 Porto Carras, GreeceDimitrios Hatzichristou, Greece1997 Madrid, SpainInigo Saenz de Tejada, Spain2000 Barcelona, SpainHalim Hattat, Turkey2001 Rome, ItalyFrancesco Montorsi, Italy2002 Hamburg, GermanyHartmut Porst, Germany2003 Istanbul, TurkeyEmre Akkus, Turkey2004 London, UKDavid Ralph, UK2005 Copenhagen, DenmarkPetter Hedlund, Sweden2006 Vienna, AustriaSiegfried Meryn, Austria2007 Lisbon, PortugalNuno Monteiro Pereira, Portugal2008 Brussels, BelgiumJoint Congress of ISSM/ESSMEric Wespes, Belgium (ISSM)Claude Schulman, Belgium (ESSM)ESSM Winter Sexual MedicineSpecialist Training Course23 – 25 November 2007, LisbonFollowing the highly successful ESSM SummerSchool Sexual Medicine Specialist Training Course,held in Oxford during July 2007, we offer a rollingprogramme of structured teaching for physiciansseeking a specialist qualification in Sexual Medicine.This programme will deliver 23 hours of structuredteaching from the European Academy ofSexual Medicine syllabus, which may be creditedtowards the 120-hour teaching requirementwhich is a component of the Academy’s Fellowshipprogramme. The programme will cover thefollowing topics: sexual dysfunctions related toother medical problems; paraphilas; practicalcommunication and counselling issues in SexualMedicine; establishing a Sexual Medicine Clinic.This 3-day residential Course will be held at theAltis Park Hotel, Lisbon, beginning at 08.30on Friday, 23rd November and concluding at14.30 on Sunday, 25th November. Only preregistereddelegates may attend; those interestedin registering for or receiving more informationabout the Fellowship programme should contactDr John Dean, at john@sexualmedicine.org.The subsequent 3-day residential (23 hours teaching)Sexual Medicine Specialist Training Coursewill be held in Rome, in April 2008. A second2-week residential (76 hours teaching) SexualMedicine Specialist Training Course will be heldduring the summer of 2008. Further informationwill be available on the ESSM website in the nextfew weeks; please send all enquiries to Dr Dean,who should be able to provide more informationby mid-December.

essm committeesExecutive CommitteePresident:PresidentElect:SecretaryGeneral:Treasurer:Members:Francesco Montorsi, ItalyIan Eardley, UKJohn Dean, UKIan Eardley, UKCarlo Bettocchi, ItalyBeatrice Cuzin, FranceBruno Giammusso, ItalyAtes Kadioglu, TurkeySiegfried Meryn, AustriaSantiago Richter, IsraelPedro Vendeira, PortugalAdvisory BoardRepresentative: Antonio Martin-MoralesScientific Committee Lisbon 2007Chair:Members:Petter Hedlund, SwedenJohn Dean, UKIan Eardley, UKAnnamaria Giraldi, DenmarkFrancois Giuliano, FranceGeoffrey Hackett, UKAntonio Martin-Morales, SpainNuno Monteiro Pereira, PortugalFrancesco Montorsi, ItalyDavid Ralph, UKMarcel D. Waldinger, The NetherlandsKevan Wylie, UKNational Organisation CommitteeChair:Members:Nuno Monteiro PereiraJosé LaFuente de CarvalhoPedro VendeiraManuel Ferreira CoelhoRicardo RamiresBelmiro ParadaMaria do Céu SantoJosé Santos DiasSub CommitteesBasic ScienceChair: Francois Giuliano, FranceMembers: Javier Angulo, SpainMario Maggi, ItalyStephan Ückert, GermanyClinicalChair:Members:EthicalChair:Members:Antonio Martin-Morales, SpainAlberto Briganti, ItalyIan Eardley, UKDirk Schultheiss, GermanyMarcel D. Waldinger, The NetherlandsUlf Simonsen, DenmarkFemale Sexual HealthChair: Annamaria Giraldi, DenmarkMembers: Ellen Laan, The NetherlandsRoy Levin, UKIlan Gruenwald, IsraelDavid Goldmeier, UKPrimary CareChair:Members:Geoffrey Hackett, UKBert-Jan de Boer, The NetherlandsDavid Edwards, UKDoug Savage, UKPsychosexualChair: Kevan Wylie, UKMembers: Loukas Athanasiadis, GreeceMarie Chevret-Measson, FranceEmmanuele Jannini, ItalyChiara Simonelli, ItalyMehmet Sungur, TurkeySurgeryChair:Members:David Ralph, UKFulvio Colombo, ItalyAntoine Faix, FranceAtes Kadioglu, TurkeySava Perovic, Serbia

essm award winners / acknowledgementsESSM Award WinnersBest Presentation Awards1995 Christian Stief, Germany1997 Paul F. Engelhardt, GermanyFrancois Giuliano, FranceSuks Minhas, UK2000 Apostolos Apostolidis, GreeceF. Mumtaz, UK2002 Annamaria Giraldi, Denmark2003 Stefan Ückert, GermanyIlan Gruenwald, IsraelMustafa Usta, TurkeyAlberto Briganti, Italy2004 Byoung Ahn, Republic of KoreaJavier Angulo, SpainAntonio Aversa, Italy2005 Giovanni Corona, ItalyElke Gizewski, GermanyHalim Hattat, TurkeyAttila Kun, HungarySava Perovic, Serbia2006 Fotini Ferenidou, GreeceGiulio Garaffa, ItalyWayne Hellstrom, USALinda Vignozzi, ItalyGuido van Wingen, The NetherlandsCareer Awards2002 John Pryor, UK2003 Gorm Wagner, Denmark2004 Giles Brindley, UKRonald Virag, France2005 Karl-Erik Andersson, SwedenAward of Excellence2002 Petter Hedlund, Sweden2003 Selim Cellek, UK2004 Stefan Ückert, Germany2005 Javier Angulo, SpainEkkehard W. Hauck, Germany2006 Andrea Salonia, ItalyAcknowledgementsThe organisers of the 10th Congress of the EuropeanSociety for Sexual Medicine gratefullyacknowledge the support of the following companies(as of November 2007)Major SponsorsBayer ScheringPharma AGEli Lillyand CompanyPfizer Inc.SponsorsAmerican Medical SystemsArdana Bioscience Ltd.Coloplast A/SIpsenJohnson and Johnson PharmaceuticalServices, LLCNature PublishingPierre Fabre MédicamentPlethora SolutionsProStrakan Group PLCSolvay Pharmaceuticals GmbHTimm Medical Technologies, Inc.Wisepress Ltd.

Lisboa Congress Center - Floor PlanOverview - Ground floorAUD VI/VIIAUD IRoom31st floorRegistrationCloakroomEntranceFoyer CEntrance areaOverview - First floorInternetCentrePosterExhibitionAUDIII/IVAUD IExhibitionPavilion 51.15EntranceSpeakersCentre LoungeExhibitionPavilion 41.081.071.061.05AUD II1.10n Auditoria and meeting roomsn Exhibitionn Poster Exhibitionn Cateringn Counter, Speaker‘s centre and Internet centre

general informationCongress LanguageThe congress language is English. Simultaneous translationwill not be provided.Publication for ProceedingsThe European Society for Sexual Medicine retains theright to publish all presented material during the congressin an ESSM publication.Congress DocumentationThe ESSM will offer its members to view parts of thescientific schedule online through a web-based systemfrom the ESSM homepage. Therefore severallectures will be filmed during the congress, whichinclude all Master Lectures, Debates, Interactive Sessions,Instructional Courses, Best Paper Sessions,Point-Counterpoint Sessions, the Round Table andVideo Session.Congress Information SystemParticipants can benefit from the web based ESSMCongress Information System CO CONGRESS ONLINE ®on-site at the Internet centre in the exhibition hall.At www.essm2007.org participants can set up andprint out a personal congress program schedule. COCONGRESS ONLINE ® offers an extensive congressservice and provides you with information on:n Updated scientific programn Program by dayn Program by formats with accepted abstracts ofchairpersons and speakersn Program searchn List of participants (who is who)n List of exhibitors and sponsorsn General congress informationn City of Lisbonn Hotel accommodationn Newsn Private mailboxSpeakers Centre and LoungeThe speakers centre and lounge is located in Room1.09 / 1.14 on the first floor.Speakers are asked to hand in their CD ROM orUSB stick, containing the PowerPoint presentation(IBM format or compatible, no multisession) preferablyone day before their presentation but at the latest90 minutes prior to the presentation. The presentationwill be transferred to the central congress serverand will be available afterwards on a special congressnotebook in the hall of the presentation. Due to timeand technical reasons we kindly ask the speakersnot to use their own notebook. Several PC workingstations are provided in the speakers’ centre wherespeakers can also work on their PC charts in a quietarea. Technical staff will be glad to assist.A speakers‘ lounge is provided in a separate area ofRoom 1.09 / 1.14. Please see as well page 7.Opening hoursSunday, 25 Nov ‘07Monday, 26 Nov ‘07Tuesday, 27 Nov ‘07Wednesday, Nov ‘0708.00 h - 19.00 h08.00 h – 18.00 h08.00 h – 18.00 h08.30 h – 13.00 hOperated by Estensis GmbH – the Conference CompanyESSM Membership IssuesFor ESSM membership issues and any other ESSMbusiness, please contact our ESSM booth which issituated in the exhibition area in Pavilion 4.Name BadgesAll participants are kindly requested to wear their namebadge at all times during the congress. The colours ofthe name badge have the following significance:Delegate:blueAccompanying person: orangePress:yellowExhibitor:greenStaff:red

general informationTechnical ExhibitionA major technical exhibition will be organised in thePavilions 4 and 5 on the first floor of the Lisboa ConventionCenter next to the main meeting rooms. Coffeebars and catering stations for lunch will be locatedin the technical exhibition. For further information,please see page 52 (List of exhibitors).Opening hoursMonday, 26 Nov ‘07Tuesday, 27 Nov ‘07Wednesday, 28 Nov ‘07Poster Exhibition09.00 h - 17.00 h09.00 h - 17.00 h09.00 h - 13.00 hAll moderated posters will be displayed in Room 3,where all moderated poster sessions will take place.You will find Room 3 on the ground floor next to theregistration counter of the congress.The unmoderated posters will be sited in Pavilion 5on the first floor of the congress venue.All moderated and unmoderated posters will be displayedduring the whole conference. They will bearranged according to topics and will be numberedwithin the topics. The poster exhibition is open to allparticipants:Opening hoursMonday, 26 Nov ‘07Tuesday, 27 Nov ‘07Wednesday, 28 Nov ‘0709.00 h - 17.00 h09.00 h - 17.00 h09.00 h - 13.00 hInterested participants can meet the authors for discussionof their posters during following times:Monday, 26 Nov ‘07Tuesday, 27 Nov ‘07Poster CD ROM16.00 h - 16.30 h16.00 h - 16.30 hA CD ROM including all poster presentations will beproduced and all delegates will receive the poster CDROM by post after the congress. All poster authorswho have not yet submitted their poster are kindlyasked to do so electronically either on CD ROM or onUSB stick at the speakers centre.Internet CentreSeveral Internet terminals are available to all delegatesat the exhibition area at the Pavilion 5 of the LisboaCongress Center. The Internet centre is accessible accordingto the opening hours of the exhibition.Wireless LanWireless LAN is installed from Monday, 26 Novemberuntil Wednesday, 28 November in the exhibition areaof Pavilion 4 and 5. A password is not required in orderto access the wireless LAN.PressThe press centre is set up in Room 1.05 and 1.06 inPavilion 4 on the first floor of the Lisboa CongressCentre and is managed by the press agency WeberShandwick | D&E.Opening hoursMonday, 26 Nov ‘07Tuesday, 27 Nov ‘07Wednesday, 28 Nov ‘07Electronic Information Boards8.00 h - 18.00 h8.00 h - 18.00 h8.00 h - 13.00 hAn information board displaying the actual scientificprogram and the news of the day will be available onthe different levels of the Congress Center.Coffee and Lunch BreaksCoffee and tea will be served during the morning andafternoon coffee breaks from Monday 26 Novemberto Wednesday, 28 November 2007 free of charge toall participants wearing congress name badges.A complimentary snack buffet will be offered duringlunch time for all registered congress delegates in theexhibition area during the congress on Monday andTuesday.RestaurantsAn additional restaurant is located in the venue whereparticipants can buy food and beverages. Various typicalPortuguese restaurants and snack bars are withinwalking distance of the congress venue.10

general informationCloakroomA cloakroom is available next to the registration counteron the ground floor. You can also store your luggagehere.BankTwo ATM machines are located inside the Lisboa CongressCenter.Lost and FoundCurrencyThe Euro is the official currency in Lisbon. Exchange offoreign currency is available at the Lisbon Airport andat most hotels, banks and exchange offices throughoutthe city.ElectricityThe local standard voltage is 220 volts and the connectionis made by a two-pin plug.A lost and found service is available at the Lisboa CongressCenter Information located in the main entranceof the congress venue.Mobile PhonesParticipants are kindly requested to keep their mobilephones turned off while attending the scientific sessionsin the meeting rooms.Program ChangesThe organisers cannot assume liability for any changesin the congress program due to external or unforeseencircumstances.InsuranceThe congress fee does not include insurance. All participantsare advised to arrange for their own insurance.Health and accident insurance is recommendedand has to be purchased in your country of residence.The organisers will not be responsible for a loss ordamage of personal belongings.Car ParkThe Lisboa Congress Center has two car parks with1.100 parking spaces. Parking fees are not includedin the registration fee.TaxisTaxis are available upon demand in front of the entranceof the Lisboa Congress Center. Participants canalso call taxis at the Lisboa Congress Center informationcounter in the entrance foyer.11

general informationHow to get to the Lisboa CongressCenterThe congress centre is served by three bus lines andone tram line:Bus number 727leaving from Roma-Areeiro towards ResteloBus number 56leaving from Olaias towards Praça das IndústriasBus number 28leaving from Portela towards ResteloTram number 15leaving from Praça da Figueira towards AlgésName of the bus stop:Rua da Junqueira (Centro de Congressos)Public Transportation PassUpon registration at the registration counter of theLisboa Convention Center all participants will receivea public transportation pass valid for all publictransportation during the congress period, i.e. fromSunday, 25 November 2007 through Wednesday, 28November 2007. Most of the hotels available are locatedwithin 20 - 30 minutes transport time from thecongress venue and there is an easy access to busesand underground transport in the city.Participants will receive the public transportation passat the congress registration counter in exchange fora voucher, which is included in the delegates’ documents.If you are travelling with bus number 28 please exit atthe bus stop Hospital Egas Moniz/Av. da Índia. Walkingdistance from the bus stop to the congress centreis approximately 100 metres.Area of Lisboa Congress CenterLisbonBus/Train Stop for the congress:Rua da Junqueira12Lisboa Congress Centre

general informationPortugalPortugal has a rich seafaring past, superb beachresorts, wistful towns and a landscape wreathed inolive groves, vineyards and wheat fields. Littered withUNESCO World Heritage sites and graced by one ofEurope’s most relaxed and attractive capitals, it alsoremains refreshingly affordable.Portugal lies immediately west of Spain, and is buffetedalong its southern coast by the Atlantic Ocean.To its west and southwest lie the islands of the Azoresand Madeira, far out in the Atlantic. It measures just560km north to south and a paltry 220km from eastto west. The northern and central regions are heavilypopulated and characterised by rivers, valleys, forestsand mountains - the highest range is the Serra daEstrela, peaking at Torre (1993m). The south is lesspopulated and, apart from the rocky backdrop of theAlgarve, much flatter and drier.In the 15th century Portugal entered a phase of overseasexpansion due to the efforts of Prince Henrythe Navigator. Mariners set off to discover new traderoutes and helped create an enormous empire that,at its peak, extended to India, the Far East, Brazil andAfrica. This period marked the apogee of Portuguesepower and wealth, but it faded towards the end ofthe 16th century. In 1755 Lisbon has been destroyedby three major earthquakes, tremors, a fire and a tidalwave. At the close of the 18th century, Napoleon sentexpeditionary forces to invade Portugal but they wereforced back by the troops of the Anglo-Portuguese alliance.During the 19th century the economy falteredand republicanism took hold. National turmoil led tothe abolition of the monarchy in 1910 and the foundingof a democratic republic. Nowadays savouringlife slowly is a Portuguese passion, and much of thebest is humble - traditional folk festivals; honest foodsimply dressed in olive oil; music that pulls at the heartstrings, recalling past love and glories; and marketsoverflowing with fish, fruit and flowers.At its heart are wide, tree-lined avenues graced byArt Nouveau buildings, mosaic pavements and streetcafes. Seen from the river - one of the city’s manygreat viewpoints - Lisbon is an impressionist pictureof low-rise ochre and pastel, punctuated by churchtowers and domes.Lisbon is the kind of place where you can sit at streetcafes - sampling food or fado - and watch the worldgo by. For the eager there are also plenty of culturalactivities. In addition to architectural masterpieces atBelém, Lisbon has over 50 museums to visit.The Torre Belem, a hexagonal chess piece, symbolisesPortugal’s glorious triumphs in the Age of Discoveries:it was from Belém that Vasco da Gama set sail for theNew World. Designed by the brilliant Arruda brothers,Diogo and Francisco, the tower is a shakennot-stirredmix of early Gothic, Byzantine and Manueline styles.Manuel I built it around 1515 to guard the entranceto Lisbon’s harbour, perhaps to catch invaders offguard.Travel to Lisbon/AirportLisbon airport is the city’s main international gatewayand located in 15 km distance to the city centre andcongress venue. The taxi fare from the airport to anyof the congress hotels and congress venue is expectedto be approximately EUR 20 and a 20-minute drive.ClimateLisbon is located in a temperate climatic zone with aCentral European climate influenced by the atlanticclimate. In November the average daytime temperatureis 15°C (63F°) and it slightly rains more than inother months.City of LisbonLisbon’s position on seven low hills beside a river oncelured traders and settlers, and it’s still a stunning site.Add to that its cultural diversity, laid-back feel andarchitectural time warp it represents one of the mostenjoyable cities in Europe.13

SUPPORTING PROGRAMTours available will be assigned on a first-come, firstservedbasis. We ask you to make your reservation inadvance before arriving in Lisbon. All tours will startand end at the Lisboa Convention Centre if not mentionedotherwise.City Sightseeing Tour -A Taste of LisbonMonday, 26 November 200714.30 – 18.00 hGetting acquainted with the most exotic capital ofEurope: The tour starts with panoramic visit of thehistorical quarter of Belem, where you will see someof the Ex Libris of the town, such as the Monument tothe Portuguese Discoveries - the Mosteiro dos Jeronimos,a jewel of manueline architecture as well as theTorre of Belem.The coach continues along the Tagus river and entersinto downtown Lisbon, the Alfama, which is the oldestarea in town where still nowadays a strong Arabicinfluence can be realised. You climb up to the CastleHill following the narrow lanes and picturesque cornersof the Alfama and finally have the “Beauty of theTagus” stretching out to your feet, once you reach theterrace of St. George Castle.Price per person: EUR 44The Magic of Sintra and the End of theContinentTuesday, 27 November 200709.00 – 13.00 hThis tour offers the opportunity to leave Lisbon behindand to discover the beauty and magical atmosphereof Sintra, recognised as a UNESCO World HeritageSite. It’s stunning setting on the north slopes of thegranite Serra, among wooden ravines and fresh watersprings made it a favour summer residence area forthe Kings of Portugal.In Sintra you visit the famous Villa Palace with an incrediblecollection of historical Portuguese tiles. Lateryou have time to explore the town of Sintra on yourown for a shopping tour.You return to Lisbon driving along the impressivecoastal road and passing by the towns of Cascais andEstoril.Price per person: EUR 53To book these tours please contact our officiallyappointed agency AIMS at the registration counterin Foyer C of the Lisboa Congress Center.For registered accompanying persons this tour iscomplimentary and necessary to reserve. Pleasecontact the registration counter.Lisbon of the DiscoveriesTuesday, 27 November 200714.30 – 17.30 hA short drive by coach takes you to the historical areaof Belem, where each stone and monument remindsyou of the glory of Portuguese discoveries that aredated back in the 15th century. A first stop is madeat the Jeronimos Monastery, declared by UNESCO asWorld Heritage, where you visit the church and itscloisters built in the unique Portuguese manuelinestyle. After a cultural introduction to Portugal, a stopat the famous Fabrica dos Pasteis de Belem will follow:a popular coffee shop were the little famous custardcakes are still produced and served freshly out ofthe oven. A bica – a small Portuguese coffee will beoffered together with the delicious cakes. Afterwardstransfer back to the congress venue.Price per person: EUR 4814

INVICORP ABBREVIATED PRESCRIBINGINFORMATION Prescribing Information(please refer to full SPC before prescribing)INVICORP solution for injectionInvicorp 25 micrograms/1mg, each dosecontaining 25 micrograms aviptadil and 1mgphentolamine mesylate in 0.35ml; Invicorp 25micrograms/2mg, each dose containing 25micrograms aviptadil and 2mg phentolaminemesylate in 0.35ml Presentation: Amber glassampoule containing 0.35ml solution forintraca ernous injection. Indication: Erectiledysfunction. Posology and method ofadministration: For men only. Initial dose is 25micrograms/1mg, administered by intracavernousinjection. Dosage can subsequently be increasedto 25 micrograms/2mg if response is inadequate.Treatment should not exceed more than oncedaily or 3 times/week with either dose. No formalstudies have been performed in elderlypatients or those with renal or hepaticimpairment. Contraindications: In men forwhom sexual activity is inadvisable orcontraindicated due to organic disease. Diseaseswhich predispose priapism (e.g. sickle cellanaemia, bone cancer, leukaemia), treatmentwith anticoagulants, hypersensitivity to activesubstances or excipients. Warnings/Precautions: Prolonged or painful erectionsmay rarely occur, particularly with anatomicaldeformities of the penis, cavernous fibrosis,Peyronie’s disease or plaque. Patients with anypainful/uncomfortable erection persisting beyond4 hours should seek urgent medical attention.Patients should be instructed in correct injectiontechnique before attempting self injection.Invicorp must be used with caution in severecardiovascular and cerebrovascular conditions.Potential risks related to intercourse in patients onmulti-drug treatment for cardiovascular symptomsmay be increased by the treatment and underlyingheart disease. Treatment should be discontinued iftachycardia occurs. Invicorp is unsuitable forconcomitant use with other treatments forerectile dysfunction. Interactions: No clinicalinteractions have been observed withantihypertensives or other cardiovascularmedicines.Undesirable effects (per injection):Common: Flushing, bruising at injection site.Uncommon: Haematoma, headache, dizziness,tachycardia, palpitations. Rare: Priapism,prolonged erections; penile nodules/fibrosis(after multiple injections), pain post injection.Very rare: Myocardial infarction, angina pectoris.Overdose: Long-term erections or priapism mayresult and require urgent medical treatment. Referto SPC for further details. D.Sp.No.9797Dispensing/supply classification: B. Price (inclVAT): To be confirmed. Reimbursement: Notavailable MA Holder: Ardana Bioscience Ltd, 38Melville Street, Edinburgh EH3 7HA, UK. MTnr:19049 and 19050 Ardana Bioscience is aregistered Trade Mark. Code: ARDINV 002. Dateof Preparation: November 2006. Aviptadil is theINN for Vasoactive Intestinal Polypeptide (VIP)Challenges inthe ED clinic:Invicorp anew choiceDr. John Dean, UKProf. Francesco Montorsi, ItalyDr. Geoff Hackett, UKPlease join us18.00-19.00Tuesday 27th November 2007Auditorium IWithin the EU, marketingauthorisations for Invicorp are currently only availablein DenmarkARD INV 024For when oral therapy doesn’t suitSatellite symposium - supported by

introduction to the scientific programStructure of the Scientific ProgramThe scientific program is structured according todays. Per day it is structured by time and room. Allpresenters are listed by name and the title of theirpresentation.Structure of the Abstract BookThe abstract book is structured by session format.The listing starts with the podium session followedby the moderated poster sessions. Hereafter the unmoderatedposters are listed according to topics.Format DescriptionsMaster LectureEach lecture of 30 minutes will be given by a distinguishedand renowned expert and will be devoted toa specific topic of major interest.Round TableThese sessions will usually last 90 minutes. They willfocus on a particular topic and present the very latestdata related to it. The round table will include a maximumof four papers and time for discussion.Best Paper SessionsA selection of the year’s original scientific publicationsof particular importance for a specific topic withinsexual medicine will be highlighted by the chairpersonsduring 60 minutes. Each paper will be brieflysummarised and discoveries or other information ofspecial interest will be given attention in relation tocurrent knowledge and future perspectives.Interactive SessionsThese sessions will last 90 minutes and present casediscussions with a questioner and a panel of experts.Attendees will be given the possibility to interactactively via a voting system with the faculty of thesession.DebatesDebates last for 60 minutes and are designed to covercontroversial issues of a particular topic. The moderatorwill allow a short introduction for each topic bythe respective opponents followed by a discussionon the arguments proposed. Comments, arguments,and questions from the floor are welcomed duringthe discussion.Point-Counterpoint SessionsThese sessions are organised to address one controversialissue of a topic. The moderator will allow abrief introduction of each topic by the respective opponentsfollowed by a discussion on the argumentsproposed.Instructional CoursesThese 90-minute sessions present a detailed accountof a chosen topic. Courses are designed to providelearning experiences that actively involve participantsand will include an opportunity for informal exchangewith the faculty.Video Surgery CourseThe Video Surgery Course will last 120 minutes, eachvideo has a duration of 12 minutes including 3 minutesfor dissussion. A panel of selected experts willpresent surgical videos showing different techniquesand approaches and will discuss the details with theparticipants.Podium SessionsPodium Sessions will present the best abstract papersaccepted for the congress by the Scientific Committeeand will focus on specific topics presenting thevery latest findings in this field. Each session will last90 minutes and will consist of max. 10 presentationsper session. Each presentation is limited to 7 minutesfollowed by 2 minutes of discussion.Moderated Poster SessionsAuthors were invited to submit papers on their latestresearch findings or important ongoing research.The moderated poster sessions were selected by theScientific Committee based on a review of all abstractsubmissions. The most interesting posters are groupedby topic and presented in a 90-minute moderatedsession. Each session will consist of a maximum of15 talks in the same general field. Each presentationis limited to 4 minutes followed by 2 minutes of discussion.PostersAuthors were invited to submit papers on their latestresearch findings or important ongoing research. Posterswere selected by the Scientific Committee basedon the review of all abstract submissions. The mostinteresting posters are grouped into one of 11 generalareas of research. The poster exhibition is scheduledfrom Monday, 26 November, 2007 to Wednesday, 28November 2007.16

introduction to the scientific programSymposia organised by the IndustrySymposia organised by the industry in consultationwith the Scientific Committee will be presented in theafternoon on Sunday, 25 November 2007 before theOpening, on Monday, 26 November 2007 and Tuesday,27 November 2007 during lunchtime and in theearly evening as well as on 28 November 2007 in themorning.CME - Continuing Medical EducationThis congress has been submitted for UEMS accreditationto the European accreditation Council for ContinuingMedical Education (EACCME). Physicians willbe accredited with CME credits for the whole periodof the congress.EACCME credits are recognised by the AmericanMedical Association towards Physician‘s RecognitionAward (PRA). To convert EACCME credit to AMA PRAcategory 1 credit, please contact the AMA. The accreditationform for international physicians is availableon the AMA website at www.ama-assn.org.Choose the button ContMedEduc (CME) and followthe link AMA PRA.This congress has been submitted for CME accreditationto the Italian Ministry of Health. Physicians will beaccredited. You will find the CME evaluation forms inyour personal documents. Italian delegates are askedto fill them in and leave them at the ESSM booth inthe exhibition area at the end of the congress. TheESSM Secretariat will send the certificate after thecongress.Grants and AwardsMeeting AwardsThe best presentations will be awarded withEUR 2.000 by ESSM’s Award Committees.1. Prize for the best presentation on FSD (preclinical)2. Prize for the best presentation on FSD (clinical)3. Prize for the best presentation on MSD (preclinical)4. Prize for the best presentation on MSD (clinical)5. Prize for the best surgical presentationThe ESSM Prestige AwardsThe Executive Committee of ESSM decided to establishtwo awards to be presented during the annualmeetings of the society:n The ESSM Career AwardThis award will be presented to a senior scientistwho has made an outstanding contribution in thefield. The Executive Committee has decided on anaward winner who will be presented during theOpening Ceremony.n The ESSM Award of ExcellenceThis award is presented annually to a physician orscientist (either in basic sciences or clinical practice)who has made recent exceptional achievementin the field. Special consideration will be given toapplications from less-experienced researchers insexual medicine.OPENING CEREMONYSunday, 25 November 2007, 18.30 h - 20.00 hThe Opening Ceremony takes place in Auditorium I at the Lisboa Congress Center includingseveral welcome speeches. Delegates will enjoy a unique blend of wonderful fado music. Singers ofseveral generations will perform a beautiful celebration of the fado - Portugal’s most famousmusic style, sometimes called the Portuguese blues.At the end of the Opening Ceremony all congress delegates and accompanying persons are invitedto join the ESSM Welcome Reception in the foyers of the Auditorium with typical Portuguesefingerfood and drinks.17

Program ScheduleSunday, 25 November 2007TimeRoomAuditorium IAuditorium VI/VIIVarious MeetingRoomsEntrance Foyer08.00 - 13.00 hMeetings ofAffiliatedSocieties08.00 - 20.00 hRegistration13.00 - 15.30 hV-01Video SurgeryCourse15.30 - 16.00 h16.00 - 17.00 hD-01The JSM Debate17.15 - 18.15 hS-02Redefining the managementof PEJohnson & Johnson18.30 - 20.00 hOpening Ceremonyfollowed by aWelcomeReception20.00 - 23.00 h Individual Dinner InvitationsAbbreviations:MLMaster LectureCPPoint Counterpoint SessionRRound TableCInstructional CourseBBest Paper SessionPPodium SessionIInteractive SessionMPModerated Poster SessionDDebateVVideo CourseSSatellite Symposium18

Program ScheduleMonday, 26 November 2007TimeRoomAuditorium IAuditoriumVI / VIIRoom 3Auditorium IIExhibition/Registration08.00 - 09.00 h09.00 - 09.30 hML-01ISSM lecture08.00 - 18.00 hRegistration09.30 - 10.00 h10.00 - 10.30 hML-02ISSWSH lectureML-03ESSM award lecture09.00 - 17.00 hExhibition/Poster Exhibition10.30 - 11.00 h COFFEE BREAK11.00 - 12.00 h12.00 - 12.30 hB-01ErectiledysfunctionCP-01 PGAD -body or mindP-01Hormones andsexuality, riskfactorsMP-01Female sexualhealthC-01Basics inejaculatorydisorders12.30 - 13.00 hML-05ESSM grantlecture13.00 - 13.30 h LUNCH BREAK13.30 - 14.30 hS-03A hard look atED treatmentPfizer Inc.14.30 - 16.00 hI-01Hormones andabnormalitiesin sexual functionP-02PathophysiologyofsexualdysfunctionsMP-02Pharmacology,hormonesC-03Basics infemale sexualhealth16.00 - 16.30 h COFFEE BREAK16.30 - 17.30 hB-02Orgasmic ejaculatorydisordersP-03Female sexualhealthC-02Basics in ED17.30 - 18.00 h18.00 - 19.30 hS-04Men’s healthcare:beyond erectiledysfunctionBayer ScheringPharma AG19.30 - 23.00 h Individual Dinner Invitations19

Program ScheduleTuesday, 27 November 2007TimeRoomAuditorium IAuditoriumVI / VIIRoom 3Auditorium IIExhibition/Registration08.00 - 09.00 hESSMBusinessMeeting07.30 - 18.00 hRegistration09.00 - 09.30 h09.30 - 10.00 h10.00 - 10.30 hML-06ESAU lectureML-07SMSNA lectureML-8EFS lecture09.00 - 17.00 hExhibition/Poster Exhibition10.30 - 11.00 h COFFEE BREAK11.00 - 12.00 h12.00 - 12.30 hB-03Female sexualdisordersCP-02HSDD - DrugsP-04EerectiledysfunctionMP-03Physiologyand pathophysiologyC-04Tricks of the trade- how to get a difficultto treat EDpatient sexuallyfunctioning12.30 - 13.00 hML-09History session13.00 - 13.30 h LUNCH BREAK13.30 - 14.30 hS-05Cardiac sexologyEli Lilly andCompany14.30 - 16.00 hI-02ErectiledysfunctionP-05EjaculatorydisordersMP-04Surgery, Peyronie’sdiseaseand priapismC-05Testosteronereplacement16.00 - 16.30 h COFFEE BREAK16.30 - 18.00 hR-01Erection/ED- a predictiveof subsequenthealth/diseaseP-06PharmacologyC-06Psychotherapeuticapproachesin prematureejaculation18.00 - 19.00 hS-06Challenges in theED clinic, ArdanaBioscience Ltd.20.00 - 24.00 h Individual Dinner Invitations20

Program ScheduleWednesday, 28 November 2007TimeRoomAuditorium I Auditorium VI/VII Room 3Exhibition/Registration08.00 - 09.00 h 08.30 - 13.00 hRegistrationB-0409.00 - 10.00 h Surgery andPeyronies disease10.00 - 10.30 hML-10ESDA sessionMP-05General issuesin sexual health,risk factors,epidemiology09.00 - 13.00 hExhibition/Poster Exhibition10.30 - 11.15 h COFFEE BREAK11.15 - 12.45 hI-03Gender dysphoria12.45 - 13.15 h Closing CeremonyS-07Current strategiesfor treating PEPlethora SolutionsP-07Surgery, Peyronie‘sdiseaseand priapismCOFFEE BREAKC-07How to implant apenile prosthesis21

scientific program, sunday, 25 November 2007V-01 Video Surgery Course13.00 - 15.30 Auditorium VI/VIIChairpersons: David Ralph, United KingdomAtes Kadioglu, TurkeySava Perovic, SerbiaV-01-01The importance of neurovascularbundle in penile reconstructivesurgeryAtes Kadioglu, TurkeyD-01 Debate16.00 - 17.00 Auditorium VI/VIIJSM Debate: Testosterone should never be givento prostate cancer survivorsChairperson: Irwin Goldstein, USAPro-Speaker: Hartmut Porst, GermanyClaude Schulman, BelgiumCon-Speaker: John Dean, United KingdomMario Maggi, ItalyV-01-02V-01-03V-01-04V-01-05V-01-06V-01-07V-01-08V-01-09V-01-10The Yachia technique for Peyronie‘sDiseaseAntoine Faix, FrancePeyronies vaginal patch and theuse of the extenderIgnacio Moncada, SpainTips and tricks in Peyronie‘s surgeryFulvio Colombo, ItalyPenile lengthening in Peyronie‘sdisease: Prosthesis implantationcombined with complete circularincisions and graftingSalvatore Sansalone, ItalyS. Perovic, P. Egydio, G. VespansianiSurgical management of genitallymphoedemaGiulio Garaffa, United KingdomD. RalphConservative surgery for penilecancerDuncan Summerton, United KingdomSurgery for BXO of the penisPaul Anderson, United KingdomHypospadias in adulthood: Inlaygraft- onlay graft urethroplastySava Perovic, SerbiaD. DjordjevicFeminising vaginoplasty for genderdysphoriaTim Terry, United KingdomS-02 Satellite Symposium17.15 - 18.15 Auditorium VI/VIIRedefining the management of prematureejaculationChairperson: Ira Sharlip, USAS-02-01S-02-02S-02-03PE InsightsIra Sharlip, USAAcute management of PE and MOAof dapoxetineFrancois Giuliano, FranceTreatment Benefits of dapoxetinein PEIra Sharlip, USAS-02-04 Redefining the Diagnosis andManagement of PE and the needto treatInvited Discussants: Hartmut Porst,Germany, Emmanuele Jannini, Italy,Siegfried Meryn, Austriasupported by Johnson and Johnson PharmaceuticalServices, LLCOpening Ceremony andWelcome Reception18.30 - 20.00 Auditorium IThe Opening Ceremony will be held in the LisboaCongress Center in Auditorium I. The welcomespeeches will be accompanied by Portuguese musicalentertainment.15.30 - 16.00 BreakAt the end of the Opening Ceremony all participantsare invited to a Welcome Reception in the foyers ofthe Auditorium I where beverages and typical localsnacks will be provided.22

scientific program, Monday, 26 November 2007ML-01Master LectureP-01 Podium Session09.00 - 09.30 Auditorium IThe ISSM lectureChairperson: John Dean, United KingdomML-01-01ML-02Premature ejaculation: A reviewand updateIra Sharlip, USAMaster Lecture11.00 - 12.30 Auditorium VI/VIIHormones and sexuality, risk factorsChairpersons: Pierre-Marc Bouloux, United KingdomDana Bucuras, RomaniaP-01-001Diagnostic and therapeutic implicationsof using calculated freetestosterone in men with low -normal total testosterone levelsSudhanshu Chitale, United KingdomK. Dhatariya, K. Sethia09.30 - 10.00 Auditorium IThe ISSWSH lectureChairperson: Annamaria Giraldi, DenmarkML-02-01Sexual desire and arousal in women- mechanisms in motionEllen TM Laan, The NetherlandsP-01-002Body weight-related differencesbetween free testosterone, adiponectinand isulin resistance inyoung men, aged 17-20 yearsMaria Todorova, BulgariaM. Baleva, Z. Kamenov, K. Ramshev,Z. Ramsheva, L. Alexiev, A. StojnevML-03Master Lecture10.00 - 10.30 Auditorium IESSM award lectureChairperson: Petter Hedlund, SwedenML-03-01The role for endothelium andtestosterone in the response toPDE5 inhibitorsAntonio Aversa, Italy10.30 - 11.00 Coffee breakB-01 Best Paper Session11.00 - 12.00 Auditorium IErectile dysfunctionChairperson: Ian Eardley, United KingdomSpeaker:Francesco Montorsi, ItalyDimitrios Hatzichristou, GreeceP-01-003P-01-004P-01-005Testosterone replacement in symptomaticlate-onset hypogonadism– clinical and metabolic responses ina randomized, placebo-controlledstudyEric Meuleman, The NetherlandsP. Bouloux, J.-J. Legros, P. Geurts,M. Kaspers, J. ElbersCAG polymorphism of androgenreceptor affects target organ responseto exogenous testosteroneDomenico Canale, ItalyC. Caglieresi, C. Moschini, A. Moscatelli,S. Gavioli, E. Martino, E. MacchiaSex steroids and leptin regulatethe KiSS 1/GPR54 system in humanolfactory GnRH-secreting neuronsAnnamaria Morelli, ItalyM. Marini, R. Mancina, M. Luconi,L. Vignozzi, B. Fibbi, S. Filippi, G. Forti,G. B. Vannelli, M. MaggiP-01-006 Prostate safety of androgenreplacement therapy: Laying stresson PSAIn Rae Cho, Republic of KoreaS. Y. Cho23

scientific program, Monday, 26 November 2007P-01-007The effect of cancer on relationshipand sexuality and the need forcounseling in an oncology patientpopulationLena Kurtz, IsraelM. Mock, Y. MametMP-01-074Impact of BPS/IC (bladder painsyndrome/interstitial cystitis) onsexual functions and partnershipsof female patientsDara Lazar, AustriaL. Daha, H. PfluegerP-01-008P-01-009P-01-010Clinical characteristics of a cohort ofgender dysphoria patients treatedwith cross-sex hormonesPedro Gutierrez, SpainP. Hernandez, M. Fernandez, D. Baez,M. MasTestosterone replacement in postgender reassignment surgery maleto-femaletranssexualLeighton Seal, United KingdomC. McHugh, E. Karra, J. Barrett, L. SealComplications of hormonal therapyin male to female transsexuals isuncommonLeighton Seal, United KingdomH. Baig, J. Barrett, S. IqbalMP-01-075MP-01-076MP-01-077Pelvic floor evaluation in an outpatientsetting. Female patientswith complaints of micturition,defecation and sexual dysfunctionare more likely to have a history ofsexual abuseJacky Beck, The NetherlandsH. Elzevier, P. Voorham - van der Zalm,H. Putter, R. PelgerPsychosexual issues in the childbearingcoupleStamatis Papaharitou, GreeceE. Nakopoulou, H. Skentou, V. Tzortzis,M. Melekos, I. MessinisSexuality in the third trimester ofpregnancyAlexandra Queiros, PortugalP. Conde, V. Cunha, F. SerranoMP-01Moderated Poster Session11.00 - 12.30 Room 3Female sexual healthChairpersons: Juza Chen, IsraelJohannes Bitzer, SwitzerlandMP-01-078 Evaluation of sexual function,quality of life and depressiveaspects in women affected by type1 diabetes mellitusMilena Tomelini, ItalyC. Gottero, M. Trento, M. TagliabueMP-01-071MP-01-072MP-01-073Sexual problems through the adultlife cycle in a sample of PortuguesewomenRui Vieira, PortugalP. PechorroEvaluation of sexual function inwomen attending an outpatienturological clinic; a survey study of436 patientsHendrik Willem Elzevier, The NetherlandsJ. Beck, R. C. Pelger, E. Laan, H. Putter,A. A. Lycklama a NijeholtEvaluation of sexual function andquality of life in women withoveractive bladderAli Sahin, TurkeyO. Demir, V. Bulut, H. Sicramaz,O. Mertoglu, E. Can, A. EsenMP-01-079Are all types of orgasm mentallyrepresented alike in a woman’sbrain? An event-related fMRI studyFrancesco Bianchi-Demicheli, SwitzerlandS. OrtigueMP-01-080 Differentiating four cognitivebehavioraltypes of women withdecreased sexual desireLorraine Dennerstein, AustraliaR. PykeMP-01-081 Cyclic AMP- and cyclic GMPbindingprotein kinases in thehuman vagina: Expression andco-localization with eNOS, VIP andPGP 9.5Stefan Ückert, GermanyE. Waldkirch, J. Sonnenberg, M. Seidler,U. Jonas, P. Hedlund24

scientific program, Monday, 26 November 2007MP-01-082 Vardenafil enhances proceptiveand receptive sexual behaviour inthe female ratHanna Tinel, GermanyP. SandnerMP-01-083MP-01-084The impact of male erectile dysfunctionon female sexual functionin GreeceAthanasios Zahariou, GreeceG. Karagiannis, M. Karamouti,E. Tyligada, P. PapaioannouQuality of sexual life changes infemale partner of men with erectiledysfunction treated with Viagra,measured by index of sexual life(ISL)Marie Chevret-Measson, FranceB. Cuzin, J. Jeanpetit, E. Jaudinot,E. LavalleeCP-01Point-Counterpoint Session12.00 - 12.30 Auditorium IPersistent Genital Arousal Disorder (PGAD) -Body or mind?Chairperson: Roy Levin, United KingdomCP-01-01CP-01-02ML-05For bodyIrwin Goldstein, USAFor mindDavid Goldmeier, United KingdomMaster Lecture12.30 - 13.00 Auditorium IESSM grant lectureChairperson: Francesco Montorsi, ItalyMP-01-085Partners‘ Preference Study: Anexamination of preference fortadalafil or sildenafil from theheterosexual partners’ perspectiveHelen Conaglen, New ZealandJ. ConaglenML-05-01ML-05-02Characterization of smooth muscletone regulation in the human seminalvesiclePonco Birowo, GermanyBotox therapy for women diagnosedwith vestibulodyniaChristina Damsted-Petersen, DenmarkC-01 Instructional Course11.00 - 12.30 Auditorium IIBasics in ejaculatory disordersChairperson: Marcel D. Waldinger, The NetherlandsC-01-01C-01-02Epidemiology of ejaculatory disordersAxel Fugl-Meyer, SwedenEndocrinology and acquired prematureejaculationEmmanuele Jannini, ItalyC-01-03 Patient preferences for drugtreatment of premature ejaculationMarcel D. Waldinger, The NetherlandsC-01-04PE drug treatment: The geometricmean IELTMarcel D. Waldinger, The Netherlands13.00 Lunch breakS-03 Satellite Symposium13.30 - 14.30 Auditorium IA hard look at ED treatment: Insights into bettersexChairperson: John Mulhall, USAS-03-01S-03-02S-03-03Treating to a goal of optimalerection hardness - Helping EDpatients attain a better sexualexperienceJohn Mulhall, USAEuropean adoption of the treatmentto goal consensusMichael Kirby, United KingdomThe role of PDE5Is in treating to goalKlaus-Peter Juenemann, Germanysupported by an educational grant from Pfizer Inc.25

scientific program, Monday, 26 November 2007I-01 Interactive Session14.30 - 16.00 Auditorium IHormones and abnormalities in sexual functionChairperson: Mario Maggi, ItalyPanel:Stefan Arver, SwedenJacques Buvat, FranceGeoffrey Hackett, United KingdomManuel Mas, SpainP-02 Podium Session14.30 - 16.00 Auditorium VI/VIIPathophysiology of sexual dysfunctionsChairpersons: Charalambos Vlachopoulos, GreeceStefan Ückert, GermanyP-02-011P-02-012P-02-013Inhibitory effect of atorvastatin onhigh-glucose induced perturbationof human penile smooth musclecells phenotype and activityAnnamaria Morelli, ItalyR. Mancina, B. Fibbi, A. Chavalmane,E. Silvestrini, M. Marini, L. Vignozzi,S. Filippi, G. B. Vannelli, M. MaggiAssociation between severity ofLUTS, erectile dysfunction andcomponents of metabolic syndromeOmer Demir, TurkeyK. Akgul, Z. Akar, O. Cakmak,I. Ozdemir, A. Bolukbasi, E. Can,B. GumusGraded association between aorticstiffness, wave reflections, andduration of vasculogenic erectiledysfunction: Linking erectile dysfunctionwith generalized vasculardiseaseCharalambos Vlachopoulos, GreeceK. Rokkas, K. Aznaouridis, N. Ioakeimidis,K. Aggeli, G. Roussakis, A. Samentzas,A. Bratsas, T. Askitis, C. StefanadisP-02-014 Erectile dysfunction and silentcoronary disease: The evidencefrom CT coronary angiographyGraham Jackson, United KingdomA. Cooper, E. McGing, C. McLeodP-02-015P-02-016P-02-017P-02-018P-02-019P-02-020Evidence that pathogenic vascularremodeling in the pudendalartery is linked to the extremesof hemodynamic stresses duringerections: Effect of antihypertensivetreatment or lifestyle modificationJohanna Hannan, CanadaJ. J. Pang, C. Smallegange, S. C. Pang,J. P. W. Heaton, M. A. AdamsCOMP-Angiopoietin-1 gene transferrestores cavernous angiogenesisand erectile function in a mousemodel of hypercholesterolemiaHwa-Yean Shin, Democratic People‘sRepublic of KoreaY. J. Koh, S. Piao, J.-K. Ryu, M. J. Choi,L.-W. Zhang, H.-R. Jin, S.-S. Hong,J.-Y. Han, G. Y. Koh, J.-K. Suh (Presenter)Increased Interleukin-18 levels andsubclinical coronary artery diseasein men with vasculogenic erectiledysfunctionNikolaos Ioakeimidis, GreeceC. Vlachopoulos, K. Rokkas, K. Baou,I. Dima, G. Antoniou, A. Samentzas,C. Fassoulakis, T. Askitis, C. StefanadisThe impact of C-type natriureticpeptide and endothelin-1 levelson sexual performance in menwith erectile dysfunction: A novelapproach to erectile dysfunctionNikolaos Ioakeimidis, GreeceC. Vlachopoulos, K. Rokkas,K. Aznaouridis, K. Baou, A. Bratsas,G. Antoniou, A. Askitis, C. StefanadisErectile dysfunction after chroniccannabis use: Is endothelialdysfunction the common denominator?Antonio Aversa, ItalyF. Rossi, R. Bruzziches, C. Bertone,D. Francomano, M. Pili, V. Santiemma,G. SperaEstimated cardiovascular risk andarteriogenic erectile dysfunctionGiovanni Corona, ItalyE. Mannucci, A. D. Fisher, F. Lotti,G. Balercia, L. Petrone, G. Forti,M. Maggi26

scientific program, Monday, 26 November 2007MP-02Moderated Poster Session14.30 - 16.00 Room 3Pharmacology, hormonesChairpersons: Emre Akkus, TurkeyGiovanni Corona, ItalyMP-02-086 Intravenous administration of7-hydroxy-2-(di-N-propylamino) tetralininduces sexual responses inanaesthetised male ratsMagali Peeters, FranceP. Clement, J. Bernabe, S. Caisey,F. Giuliano (Presenter)MP-02-087 FK506 and erectile functionpreservation in the cavernousnerve injury model: Optimal dosingand timingAlexander Müller, SwitzerlandJ. Donohue, R. Tal, K. Kobylarz,T. Sulser, P. Scardino, J. MulhallMP-02-088 Bilateral cavernous neurotomyinduces hypogonadotropic hypogonadismin rat: Effect of testosteroneand tadalafil supplementationSandra Filippi, ItalyA. Morelli, L. Vignozzi, R. Mancina,E. Silvestrini, A. Chavalmane, M. Marini,G. B. Vannelli, M. MaggiMP-02-089 Cyclic AMP-dependent proteinkinase-I alpha is involved in therelaxation of human cavernousarteries exerted by PDE5 inhibitorsEginhard Waldkirch, GermanyS. Ueckert, J. Sonnenberg, F. Imkamp,M. Seidler, M. Sohn, U. Jonas,J. E. Sonnenberg, P. HedlundMP-02-090MP-02-091Mechanisms of the relaxant effectof vardenafil in rat penile arteriesAna Sanchez, SpainN. Villaba, M. Monroy, A. GarciaSacristan, M. Hernandez, D. PrietoValidation of electronic stopwatchmeasurements of erection durationagainst responses to the sexualencounter profile and internationalindex of erectile functionJames Shaw, USAG. Reardon, D. Sandor, R. Rosen,D. FergusonMP-02-092MP-02-093MP-02-094MP-02-095MP-02-096MP-02-097A comparison of vardenafil andsildenafil: Efficacy among men witherectile dysfunction and relatedcomorbiditiesEusebio Rubio-Aurioles, MexicoH. Porst, I. Eardley, I. GoldsteinRelationship between successfulsexual intercourse and the erectionhardness scoreJohn Mulhall, USAI. Goldstein, A. Bushmakin, J. Cappelleri,K. Hvidsten, T. SymondsVardenafil treatment of erectiledysfunction in depressive and nondepressivemen (VALOR study)– pilot results from 958 PolishpatientsBarbara Darewicz, PolandJ. Kudelski, M. Chlabicz, M. Wronka,B. Kozlowska-BoszkoA comparison of vardenafil andsildenafil: Treatment preferenceand satisfaction among men withED and related comorbiditiesEusebio Rubio-Aurioles, MexicoH. Porst, I. Eardley, I. GoldsteinA double-blind, randomized, placebo-controlled,crossover study toeva-luate changes in retinal functionin healthy males after multiple dosesof the phosphodiesterase type-5inhibitor vardenafilAlexander Brucker, USAD. Scheraga (Presenter), S. Boxley, J. Dupont,J. Gausas, M. Al-BannaTadalafil 5 mg or sildenafil citrate50 mg administered daily for upto 6 months does not affect visualsafetyWilliam H. Cordell, USAR. K. Maturi, T. M. Costigan, M. F. Marmor,R. G. Weleber, S. G. Coupland,R. P. Danis, J. W. McGettigan, Jr,A. N. Antoszyk, S. Klise, G. D. Sides,R. K. Maturi (Presenter)27

scientific program, Monday, 26 November 2007MP-02-098 Combination of alfuzosin andtadalafil exerts an additive relaxingeffect on precontracted humancorpus cavernosumStephanie Oger-Roussel, FranceD. Behr-Roussel, D. Gorny, J.-C. Tremeaux,M. Combes, J. Bernabe, L. Alexandre,F. GiulianoMP-02-099MP-02-100NS11021, a novel opener of largeconductanceCa2+-activated K+channelsenhances erectile responses inratsAttila Kun, HungaryA. Nardi, J. Demnitz, U. SimonsenAtorvastatin ameliorates penile erectionand sildenafil responsivenessin two distinct animal models ofchemical diabetesAnnamaria Morelli, ItalyS. Filippi, L. Vignozzi, X.-H. Zhang,R. Mancina, A. Chavalmane,E. Silvestrini, M. MaggiC-03 Instructional Course14.30 - 16.00 Auditorium IIBasics in female sexual healthChairperson: Ilan Gruenwald, IsraelC-03-01C-03-02C-03-03What do we know on the physiologyof orgasm?Roy Levin, United KingdomThe new pharmacological approachesto FSDIlan Gruenwald, IsraelDyspareunia, etiology and treatmentChristina Damsted-Petersen, DenmarkC-03-04 Positive and negative factorseffecting sexual desireAgnes Kocsis, United Kingdom16.00 - 16.30 Coffee breakB-02 Best Paper Session16.30 - 17.30 Auditorium VI/VIIOrgasmic and ejaculatory disordersChairperson: Marcel D. Waldinger, The NetherlandsSpeakers:Francois Giuliano, FranceChris McMahon, AustraliaP-03 Podium Session16.30 - 18.00 Room 3Female sexual healthChairpersons: Rik van Lunsen, The NetherlandsJudith Alder, SwitzerlandP-03-021P-03-022Beyond cerebral networks of women’ssexual pleasureStephanie Ortigue, USAF. Bianchi-Demicheli, S. GraftonThe P300 method for libido assessmentapplied to HSDD patientsYoram Vardi, IsraelI. Gruenwald (Presenter), S. Eliot,G. Yelena, D. YarnitskyP-03-023 Sexual difficulties after breastcancer: Whom can we blame?Judith Alder, SwitzerlandR. Zanetti, J. BitzerP-03-024P-03-025Development and validation of anew distress measure for femalesexual dysfunction – women’ssexual distress questionnaire(WSDQ)Lucy Abraham, United KingdomT. Symonds, K. May, L. R. DeRogatis,D. L. Patrick, M. L. Martin, D. M. BushnellUsing e-Diaries to measure sexualdesire in women with hypoactivesexual desire disorderAnita Clayton, USAR. van Lunsen, R. Nappi, J. Tignol,D. Goldmeier, D. Lewis-D‘Agostino,R. Pyke, G. Wunderlich28

scientific program, Monday, 26 November 2007P-03-026Validation of the sexual interestand desire inventory-female(SIDI-F) in European womenRik van Lunsen, The NetherlandsR. Nappi, J. Tignol, D. Goldmeier,R. Pyke, H. StaehleS-04 Satellite Symposium18.00 - 19.30 Auditorium IMen’s healthcare: beyond erectile dysfunctionChairperson: Jacques Buvat, FranceP-03-027P-03-029Nasal testosterone shifts memoryoperations towards male faces inwomenGuido van Wingen, The NetherlandsC. Mattern, R. J. Verkes, J. Buitelaar,G. FernandezEffect of estrogen on the expressionof aquaporins in rat vaginaSun-Ouck Kim, Republic of KoreaK. Park, H.-S. Lee, S. W. Kim, S. I. Jung,K. AhnP-03-030 Clitoral blood flow changesafter surgery for stress urinaryincontinence: Pilot study on TVT vs.TOT proceduresSalvatore Caruso, ItalyS. Rugolo, S. Bandiera, D. Mirabella,A. Cavallaro, A. CianciS-04-01 Current perspectives in men’shealthcare: erectile dysfunction,testosterone deficiency and underlyingconditionsRaymond C. Rosen, USAS-04-02S-04-03The benefits of testosterone therapy:results from two studies in men withtestosterone deficiencyPierre-Marc Bouloux, United KingdomErectile dysfunction in men withunderlying conditions: experienceswith vardenafilIan Eardley, United Kingdomsupported by an educational grant from BayerSchering Pharma AGC-02 Instructional Course16.30 - 18.00 Auditorium IIBasics in EDChairperson: Ian Eardley, United KingdomC-02-01Anatomy and physiologyFerdinando Fusco, ItalyPlease visit the Technical ExhibitionOpening hoursMonday, 26 Nov ‘0709.00 h - 17.00 hTuesday, 27 Nov ‘0709.00 h - 17.00 hWednesday, 28 Nov ‘07 09.00 h - 13.00 hC-02-02C-02-03Assessment and physical examinationBert Jan de Boer, NetherlandsTreatmentIan Eardley, United Kingdom29

scientific program, Tuesday, 27 November 2007ESSM Business Meeting08.00 - 09.00 Auditorium VI/VIIMembers onlyML-06Master Lecture09.00 - 09.30 Auditorium IThe ESAU lectureChairperson: Vincenzo Mirone, ItalyML-06-01ML-07Peyronie’s disease – the ancient andthe newWolfgang Weidner, GermanyMaster Lecture09.30 - 10.00 Auditorium IThe SMSNA lectureChairperson: Antonio Martin-Morales, SpainML-07-01ML-08Human gene therapy in ED – anupdateGeorge Christ, USAMaster Lecture10.00 - 10.30 Auditorium IThe EFS lectureChairperson: Antonio Jose Pacheco Palha, PortugalML-08-01Cognitive behavioural techniquesfor EDPedro Nobre, Portugal10.30 - 11.00 Coffee breakB-03 Best Paper Session11.00 - 12.00 Auditorium IFemale sexual disordersChairperson: John Dean, United KingdomSpeakers:Annamaria Giraldi, DenmarkAndrea Salonia, ItalyP-04 Podium Session11.00 - 12.30 Auditorium VI/VIIErectile dysfunctionChairpersons: David Edwards, United KingdomAlberto Briganti, ItalyP-04-031P-04-032P-04-033P-04-034Male dyspareunia: A prospectivesurveyPierre Bondil, FranceF. Ozone, K. Bouraoui, A. Demey,F. Adawi, X. TaccoenAssociation between psychiatricsymptoms and erectile dysfunctionGiovanni Corona, ItalyV. Ricca, E. Bandini, E. Mannucci,L. Petrone, A. D. Fisher, F. Lotti,G. Balercia, C. Faravelli, G. Forti,M. MaggiSexual function and quality of lifein men with spinal cord injuryInbal Pe‘er-Arazy, IsraelD. Justo, A. Ohry, R. J. Heruti,D. Justo (Presenter)Associations between female partnerattitudes and male-partnererectile dysfunction, treatment-seekingbehaviour and treatment utilisation:Findings of the FEMALESstudyIan Eardley, United KingdomW. Fisher, M. McCabe, M. SandP-04-035 Attitudes towards erectiledysfunction (ED) and its treatmentDavid Edwards, United KingdomC. Hood, O. CollinsP-04-036Effect of on- demand Sildenafilin sexually healthy males - Arandomized placebo controlleddouble blind studyIlan Gruenwald, IsraelO. Massarwa, Y. VardiP-04-037 Chronic sildenafil treatmentimproves penile, but non systemic,endothelial function in patientswith EDBoaz Appel, IsraelI. Gruenwald, Y. Ofer, L. Dayan,G. Jacob, Y. Vardi30

scientific program, Tuesday, 27 November 2007P-04-038Intrafascial nerve sparing techniqueimproves the rate of erectilefunction recovery after retropubicradical prostatectomy, compared tostandard techniqueAlberto Briganti, ItalyA. Gallina, A. Salonia, F. Deho,G. Zanni, F. Sozzi, E. Strada,U. Capitanio, N. Suardi, P. Rigatti,F. MontorsiMP-03-104Interrelationships of monocytecount with penile vasculardamage, carotid intima-mediathickness and aortic stiffnessin patients with vasculogenicerectile dysfunctionNikolaos Ioakeimidis, GreeceC. Vlachopoulos, K. Rokkas, I. Dima,K. Aznaouridis, A. Tsokanis, A. Samentzas,T. Askitis, C. StefanadisP-04-039 Time to continence recoveryis an independent predictor oferectile function recovery afterbilateral nerve sparing radicalprostatectomyAlberto Briganti, ItalyA. Gallina, A. Salonia, F. Deho,G. Zanni, F. Pellucchi, U. Capitanio,F. Sozzi, N. Suardi, P. Rigatti,F. MontorsiP-04-040MP-03Two years follow-up with lowdosesildenafil for rehabilitationof erectile function after nervesparingradical prostatectomyAndreas Bannowsky, GermanyH. Schulze, C. van der Horst, S. Hautmann,K.-P. JünemannModerated Poster Session11.00 - 12.30 Room 3Physiology and pathophysiologyChairpersons: Ulf Simonsen, DenmarkJavier Angulo, SpainMP-03-101 Body image and sexuality inindividuals self presented as withand without sexual difficultiesPatricia Pascoal, PortugalA. BeatoMP-03-102 The psychological impact ofdermatological diseases on sexualfunction in young menIoannis Vakalopoulos , Greece (Presenter)F. DimitriadisMP-03-103Characterization of vascular andsmooth muscle cell structure inhuman erectile tissueCarla Costa, PortugalR. Soares, V. Hastert, P. Vendeira,R. ViragMP-03-105Correlation between penile Dopplerfindings and C-reactive proteinlevels in patients with erectiledysfunction of vascular originKonstantinos Rokkas, GreeceC. Vlachopoulos, N. Ioakeimidis,A. Samentzas, N. Alexopoulos,A. Tsokanis, T. Askitis, C. StefanadisMP-03-106 Flow-evoked vasodilatation isblunted in penile arteries fromzucker obese diabetic ratsOlav Schjoerring, DenmarkA. Kun, A. Flyvbjerg, H. J. Kirkeby,J. B. Jensen, U. SimonsenMP-03-107MP-03-108MP-03-109Association between arterial wavereflections and penile Dopplerfindings in hypertensive men withvasculogenic erectile dysfunctionCharalambos Vlachopoulos, GreeceN. Ioakeimidis, A. Tsokanis, K. Rokkas,A. Bratsas, A. Samentzas, K. Tzannos,S. Leontis, C. Fassoulakis, C. StefanadisUltrasound evaluation of possiblesystemic endothelial protection inducedby tadalafil long term usagein diabetes erectile dysfunctionVasile Coca, RomaniaS. Pop, I. Coman, M. C. Coca, N. HancuGene transfer of ion channelsreduce intracellular Ca2+ in humancorporal smooth muscle cellsSung Won Lee, Republic of KoreaM. R. Chae, J. H. Jung, I. So, J. K. ParkMP-03-110 Human growth hormone (GH)interacts with the cyclic gmpsignaling in isolated human penileerectile tissueArmin Becker, GermanyF. Scheller, U. Jonas, C. Stief, S. Ückert31

scientific program, Tuesday, 27 November 2007MP-03-111Influence of A5 Androstenediol declinein aging male. On bioavailabletestosterone calculationJean-Pierre Raynaud, FranceMP-03-112 Evaluating the relationshipbetween lower urinary tractsymptoms (LUTS) associated withbenign prostatic hyperplasia (BPH)and erectile dysfunction: Role ofautonomic hyperactivityMehmet Umul, TurkeyB. Altay, F. Bademkiran, B. Turna,B. Semerci, E. Apaydin, N. CikiliMP-03-113 Interest of a guide withtriiodothyronin neuroregenerativemedium for erectile function recoveryin a rat model of cavernousnerve injuryThomas Bessede, FranceB. Alsaid, J. Bernabe, F. Giuliano,J. Quillard, G. Beboit, S. DroupyMP-03-114The effect of hyperbaric oxygentherapy on erectile functionrecovery in a rat cavernous nerveinjury modelAlexander Müller, SwitzerlandR. Tal, J. Donohue, K. Kobylarz,T. Sulser, P. Scardino, J. MulhallMP-03-115 Pharmacological prophylaxis oferectile dysfunction after radicalprostatectomy with VardenafilSafail Gamidov, RussiaE. Mazo, M. GuseinovC-04 Instructional Course11.00 - 12.30 Auditorium IITricks of the trade - how to get a difficult to treatED patient sexually functioningChairpersons: Hartmut Porst, GermanyMichael Sohn, GermanyC-04-01C-04-02CP-02The conservative tricks of the tradeHartmut Porst, GermanyThe surgical tricks of the tradeMichael Sohn, GermanyPoint-Counterpoint Session12.00 - 12.30 Auditorium IHyposexual Desire Disorder (HSDD) – Can wetreat it with drugs?Chairperson: Loukas Athanasiadis, GreecePro-Speaker: Rossella Nappi, ItalyCon-Speaker: Desa Markovic, United KingdomML-09Master Lecture12.30 - 13.00 Auditorium IESSM history sessionChairperson: Dirk Schultheiss, GermanyML-09-01Life and work of Egas Moniz – fromsexology to the Nobel PrizeNuno Monteiro Pereira, Portugal13.00 Lunch break32

scientific program, Tuesday, 27 November 2007S-05 Satellite Symposium13.30 - 14.30 Auditorium ICardiac sexology: Can we save a patient‘s lifeand his love life?Chairperson: Graham Jackson, United KingdomS-05-01 New horizons in erectile andendothelial dysfunction researchand therapiesFrancois Giuliano, FranceS-05-02Prevention of cardiovascular diseaseby early identification of EDGraham Jackson, United KingdomS-05-03 Understanding individuals‘ responseto erectile dysfunctionDimitrios Hatzichristou, Greecesupported by an educational grant from Eli Lilly andCompanyP-05-042 Oxytocin receptor antagonistacts at the brain level to inhibitejaculation in anaesthetised ratsPierre Clement, FranceM. Peeters, J. Bernabe, M. Laurin,F. Giuliano (Presenter)P-05-043P-05-044Prevalence of premature ejaculationin chronic pelvic pain syndromeIn Rae Cho, Republic of KoreaS. Y. ChoAssociation between prematureejaculation and LUTS severityOmer Demir, TurkeyK. Akgül, Z. Akar, O. Cakmak,I. Ozdemir, A. Bolukbasi, E. Can,B. GumusP-05-045 Inter-relationships among outcomesrelated to prematureejaculation: Analyses from aEuropean observational studyFrancois Giuliano, FranceD. Patrick, M. Rothman, J. BerlinI-02 Interactive Session14.30 - 16.00 Auditorium IErectile dysfunctionChairperson: Beatrice Cuzin, FrancePanel:Edoardo S. Pescatori, ItalyThierry Roumeguere, BelgiumPeter Stroberg, SwedenPedro Vendeira, PortugalP-05 Podium Session14.30 - 16.00 Auditorium VI/VIIEjaculatory disordersChairpersons: Marcel D. Waldinger, The NetherlandsNuno Monteiro Pereira, PortugalP-05-041Involvement of cortical serotonergicpathways in sexual behaviourin the male ratChiara Pozzato, ItalyG. Hedou, C. Heidbreder, P. A. Gerrard,R. Arban, S. MelottoP-05-046P-05-047P-05-048P-05-049DA8031, a selective and potentserotonin transporter inhibitor, inhibitsp-chloramphetamine-inducedejaculation in ratsByoung Ahn, Republic of KoreaK. K. Kang, Y. G. Lee, S. M. Choi,D. S. Kim, M. YooImprovements in premature ejaculationoutcomes in “responders” todapoxetineJacques Buvat, FranceF. Giuliano, S. Bull, F. Tesfaye, M. Rothman,D. RivasA double blind, placebo controlled,randomised crossover study toinvestigate the effect of inhaleddoses of VR776 on intravaginalejaculatory latency in patients withpremature ejaculationBrian Leaker, United KingdomP. Kell, M. Main, D. RalphEffects of vardenafil in youngmen with idiopathic prematureejaculationMarcello Pili, ItalyR. Bruzziches, E. A. Greco, D. Francomano,G. Spera, A. Aversa33

scientific program, Tuesday, 27 November 200734P-05-050 Comparison of fluoxetine vs.fluoxetine + tadalafil in the treatmentof premature ejaculationadouble blind, placebo controlstudyMelih Culha, TurkeyL. Ozkan, C. Ozkurkcugil, A. GokalpMP-04Moderated Poster Session14.30 - 16.00 Room 3Surgery, Peyronie’s disease and priapismChairpersons: Antonio Martin-Morales, SpainPeter Scheplev, RussiaMP-04-116MP-04-117MP-04-118MP-04-119MP-04-120MP-04-121Location and nature of nervesfibres in the inferior hypogastricplexus and its efferent’s nerves inhuman fetusBayan Alsaid, FranceI. Karam, T. Bessede, I. Abd-Alsamad,J. F. Uhl, V. Delmas, G. Benoit, S. DroupyFixation of the neovaginal vaultto Coopers’ ligament in male tofemale transgender patientsPeter Rehder, AustriaG.-M. Pinggera, R. Herwig, C. GozziNeovaginal prolapse prevention inmale transsexuals by sacrospinousligament fixationDusan Stanojevic, SerbiaM. Djordjevic, V. Kojovic, M. Bizic,M. Majstorovic, S. PerovicAlbuginea modelling and oversizingimplantation in severedeformed and short penis: 5 yearsfollow-upOmidreza Sedigh, ItalyM. Paradiso, F. Liberale, M. E. Graziano,F. Morabito, U. FerrandoReal penile lengthening by corporotomysingle incision, based ongeometrical principle, combinedwith simultaneous prosthesis implantationDmitry Kurbatov, RussiaCircumcision is not mandatory inpenile surgeryGiulio Garaffa, United KingdomN. Christopher, D. RalphMP-04-122MP-04-123MP-04-124Sexual function after reconstructiveurethroplasty for anterior urethralstricturesPeter Scheplev, RussiaB. Gvasaliya, N. GarinPreliminary results of use of freepreputial graft in the treatment ofpenile curvaturesDemetrios Radopoulos, GreeceI. Vakalopoulos, P. Thanos, P. DemetriadisReduction corporoplasty for thesurgical treatment of geometricerectile dysfunctionSava Perovic, SerbiaR. Djinovic, D. Basic, S. SansaloneMP-04-125 Long-term outcome of penilecorporoplasty for correction ofPeyronie’s disease: Our departmentexperienceNuno Tomada, PortugalI. Lopes, P. VendeiraMP-04-126MP-04-127MP-04-128MP-04-129Surgical treatment of Peyronie’sdisease: A single center experiencewith 145 patientsTolga Akman, TurkeyO. Sanli, K. Onem, T. Tefik, A. Amasyali,A. Kadioglu (Presenter)Intracavernous injections of corticoidsare efficient for painful LaPeyronie diseasePierre Bondil, FranceA. Demey, F. Ozone, B. Knouzy,K. BouraouiThe use of bovine pericardium forPeyronie‘s disease. PreliminaryresultsAristomenis Gekas, GreeceP. Kartsaklis, C. Konstantinidis, I. Palaiodimos,S. AndreadakisAdvance in local treatment ofPeyronie‘s disease: Intralesionalinjection using a new plungermechanism syringe with ergonomicleverage handlingAlessandro Zucchi, ItalyF. Fioretti, E. Mearini, G. Tuffu, M. Bitelli,S. Perovic

scientific program, Tuesday, 27 November 2007MP-04-130New selection criteria for surgicaltreatment of Peyronie‘s diseaseMariano Rossello, SpainA. Mus, G. CondeC-05 Instructional Course14.30 - 16.00 Auditorium IITestosterone Replacement – “Starting with thepatient”tChairperson: John Dean, United KingdomGeoffrey Hackett, United KingdomUsing “real patient” case studies from hospital andprimary care, this course offers a practical guide toidentifying, counselling and treating patients with testosteronedeficiency. It will explore testosterone bothin Sexual Medicine and in the broader issues of men’shealth. Participants will be asked to join in the decision-makingprocess, testing their own knowledgeand developing their skills in this important issue.16.00 - 16.30 Coffee breakR-01 Round Table16.30 - 18.00 Auditorium VI/VIIErection – a predictive of subsequent health/ED– a predictive of subsequent diseaseChairperson: Siegfried Meryn, AustriaR-01-01R-02-02R-01-03The cardiac urologist or urologicalcardiologistPiero Montorsi, ItalyPremonitory sign of metabolicanomalitiesSiegfried Meryn, AustriaTestosterone, erectile function andlinks to other health-risk factors?Claude Schulman, BelgiumP-06 Podium Session16.30 - 18.00 Room 3PharmacologyChairpersons: Ian Eardley, United KingdomPetter Hedlund, SwedenP-06-051P-06-052P-06-053P-06-054Phase IIb efficacy and safety ofbremelanotide in the treatment ofnon-diabetic males with erectiledysfunctionStanley E. Althof, USASafety and efficacy of orally inhaledapomorphine (VR004) in the treatmentof erectile dysfunctionFrazer Morgan, United KingdomA. Riley, M. MainLong-term safety and efficacy of5 mg tadalafil dosed once daily inmen with erectile dysfunctionHartmut Porst, GermanyJ. Rajfer, A. Casabe, R. Feldman,D. Ralph, L. Vieiralves, A. Esler, S. KliseWhat characteristics are associatedwith phosphodiesterase type5 inhibitor adverse events?Classification and regression treeanalyses in 3488 tadalafil-treatedmen with erectile dysfunctionGerald Brock, CanadaS. Glina, I. Moncada, S. Watts, L. Xu,V. KopernickyP-06-055 Efficacy and safety of oralmirodenafil in the treatment ofmen with erectile dysfunction: amulti-center, randomized, doubleblind, placebo-controlled, fixeddose, parallel group clinical trialJae-Seung Paick, Republic of KoreaH.-K. Choi, S.-C. Kim, J.-K. Suh, T.-Y.Ahn, J.-J. Kim, J.-K. Park, W.-S. Chung,K.-S. Park, S.-W. Lee, D.-Y. Yang,S.-W. Kim, K.-S. Min, K.-H. Moon,N.-C. ParkR-01-04Penis, prostate and PDE5Kevin T. McVary, USA35

scientific program, Tuesday, 27 November 2007P-06-056Efficacy and safety of fixed-doseUdenafil (Zydena ® ) in men withdiabetes and erectile dysfunctionJe Jong Kim, Republic of KoreaD. Y. Yang, C. H. Lee, T. Y. Ahn,K. S. Min, K. Park, J. K. Park, C. H. LeeP-06-057 Varenicline combined with ondemand sildenafil 100 mg in heavysmokers complaining of difficultto-treaterectile dysfunction.Preliminary results at a single majortertiary academic centreAlberto Briganti, ItalyA. Salonia, F. Pellucchi, R. Matloob,A. Gallina, F. Deho, G. Zanni, M. Raber,P. Rigatti, F. MontorsiC-06 Instructional Course16.30 - 18.00 Auditorium IIPsychotherapeutic approaches in prematureejaculationChairperson: Betty Ann Muir, United KingdomC-06-01Cognitive behavioral approachesin the treatment of prematureejaculationMehmet Sungur, TurkeyC-06-02 Treatment resistant cases ofpremature ejaculation: A psychoanalyticalapproachMarie Chevret-Measson, FranceP-06-058P-06-059P-06-060Comparable efficacy of once-dailyvs on-demand vardenafil in menwith mild or mild-to-moderate ED:The RESTORE studyJürgen Zumbe, GermanyH. Porst, F. Sommer, W. Grohmann,M. Beneke, E. UlbrichEfficacy and safety of a newtestosterone-in-adhesive matrixpatch applied every two days forone year to hypogonadal menJean-Pierre Raynaud, FranceJ.-J. Legros, J. Rollet, M. Auges,P. Bunouf, M. Sournac, J. FietLate-onset hypogonadism in theaging male: Effects of treatmentwith a 1% testosterone gel (Testogel® ) on health-related quality oflifePierre-Marc Bouloux, United KingdomJ. Kelly, F. HiemeyerC-06-03 An integrative approach topremature ejaculation – emotionaland relationship perspectivesChiara Simonelli, ItalyS-06 Satellite Symposium18.00 - 19.00 Auditorium IChallenges in the ED clinic: Invicorp a new choiceChairperson: John Dean, United KingdomS-06-01S-06-02S-06-03Patients resistant to oral therapy:the current optionsFrancesco Montorsi, ItalyInvicorp: a novel injection therapyfor EDGeoffrey Hackett, United KingdomInvicorp in the clinic: case studydiscussionsupported by an educational grant from ArdanaBioscience Ltd.36

scientific program, Wednesday, 28 November 2007B-04 Best Paper Session09.00 - 10.00 Auditorium ISurgery and Peyronies diseaseChairperson: David Ralph, United KingdomSpeaker:MP-05Fulvio Colombo, ItalyAntoine Faix, FranceModerated Poster Session09.00 - 10.30 Room 3MP-05-136Rigiscan monitoring of nocturnaltumescence in patients with lowtestosterone level treated withtestosterone undecanoateAksam Yassin, GermanyA. Shamsodini, F. Saad, R. Alzubaidi,A. Al Ansari, S. AlkadiMP-05-137 The early period result ofvasectomy: Effects on the qualityof life and erectile functionAli F Pahin, TurkeyG. Yildiz, B. Tuncay, F. ZorluGeneral issues in sexual health, risk factors,epidemiologyChairpersons: Ignacio Moncada, SpainEginhard Waldkirch, GermanyMP-05-138A study on blood and seminalserotonin level in married couplewith infertilityMona Reda, EgyptMP-05-131MP-05-132MP-05-133MP-05-134Plasma levels of asymmetric dimethylarginine(ADMA) in relation tovasculogenic erectile dysfunction inessential hypertensive patientsCharalambos Vlachopoulos, GreeceN. Ioakeimidis, K. Rokkas, K. Aznaouridis,K. Baou, A. Samentzas, T. AskitisDifferential endothelial dysfunctionin penile and coronary arteriesduring metabolic syndromeDolores Prieto, SpainN. Villalba, A. Sanchez, M. Hernandez,A. Garcia-Sacristan, S. BeneditoErectile dysfunction (ED) as earlymarker of cerebral ischaemicdamage. Is it useful performingneurological investigations?Paolo Maria Michetti, ItalyM. Zaccagnini, E. Vicentini, V. Del Piero,M. Altieri, H. Shahabadi, M. Ciccariello,C. De DominicisBrazilian aging male populationstudyCarmita Abdo, BrazilJ. Afif-AbdoMP-05-135 NCEP-ATP-III defined metabolicsyndrome, type 2 diabetes mellitusand prevalence of hypogonadismin male patients with sexualdysfunctionGiovanni Corona, ItalyE. Mannucci, L. Petrone, G. Belercia,F. Paggi, A. D. Fisher, F. Lotti, V. Chiarini,G. Forti, M. MaggiMP-05-139Dapoxetine has no effects onhemodynamics or electrocardiographicassessmentsNishit B. Modi, USAR. Nath, B. Wang, D. Rivas (Presenter),S. K. GuptaMP-05-140 Chronic illness and sexuality:Patients‘ perceptionAntoine Lemaire, FranceB. AlexandreMP-05-141MP-05-142MP-05-143Couple perceptions and attitudestowards erectile dysfunction: Findingsof the FEMALES studyIan Eardley, United KingdomW. Fisher, M. McCabe, M. SandValidation and psychometric propertiesof the English-languageversion of the female assessment ofmale erectile dysfunction detectionscale (FAME)Eusebio Rubio-Aurioles, MexicoJ. Dean, J. Longworth, I. Eardley,G. Brock, J. LeeSexual dysfunctions and mentalhealth in haemodialysed patients- ASED multicenter studyMichal Lew-Starowicz, PolandZ. Lew-Starowicz, R. GellertMP-05-144 Personality characteristics in aforensic sample of child sexualabusersPedro Pechorro, PortugalR. Vieira, C. Poiares37

scientific program, Wednesday, 28 November 2007MP-05-145 Psychometric validation of thesexual distress evaluation questionnairefor men (SDEQ-M)Valeria Ugolini, ItalyE. Macri, M. Capone, C. Ceruti,G. Franco, V. Gentile, B. Giammusso,G. Ludovico, E. S. Pescatori, F. PirozziFarina, G. Piubello, T. Scalvini, M. Soli,P. Turchi, L. Vaggi, M. Vetri,E. S. Pescatori (Presenter)ML-10Master Lecture10.00 - 10.30 Auditorium IESDA Session: Listening and learning frompatientsChairpersons: Michael Berner, GermanyIgnacio Moncada, SpainML-10-01 Listening to male patients inhelplinesStamatis Papaharitou, GreeceML-10-02ML-10-03Listening to female patients inhelplinesMichael Berner, GermanyLearning from each otherIrem Hattat, TurkeyS-07 Satellite Symposium10.30 - 11.15 Auditorium VI/VIICurrent strategies for treating prematureejaculationChairpersons: John Dean, United KingdomMichael G Wyllie, United KingdomS-07-01S-07-02Definition and diagnosis of prematureejaculation: Is there needfor a change?Marcel D. Waldinger, The NetherlandsTreatment Options for PrematureEjaculationChris McMahon, Australiasupported by an educational grant from PlethoraSolutionsI-03 Interactive Session11.15 - 12.45 Auditorium IGender dysphoriaChairperson: Kevan Wylie, United KingdomI-03-01 The role of psychotherapysupporting the RLEWalter Bockting, The NetherlandsI-03-02I-03-03I-03-04The role of the psychiatrist inassessing patients with GDAudrey Gorin, FranceMireille Bonierbale, FranceThe endocrinological treatmentsfor patients with GDEmmanuele Jannini, ItalySurgical aspectsMichael Sohn, GermanyP-07 Podium Session11.15 - 12.45 Auditorium VI/VIISurgery, Peyronie‘s disease and priapismChairpersons: Trygve Talseth, SwedenJuan Ignacio Martinez-Salamanca, USAP-07-061 Genital flaps combined withbuccal mucosa graft for urethralreconstruction in female transsexualsDusan Stanojevic, SerbiaV. Kojovic, M. Bizic, M. Majstorovic,S. Perovic, M. DjordjevicP-07-062P-07-063Factors affecting the degree ofpenile deformity in Peyronie’sdisease: Analysis of 1001 patientsTolga Akman, TurkeyO. Sanli, M. Atar, T. Mut, F. Kücükdurmaz,A. KadiogluGrafting with auto-, xeno- andheterotransplants in Peyronie’sdisease treatmentPeter Scheplev, RussiaI. Danilov, B. Gvasaliya, N. Garin,A. Kolotinskiy10.30 -11.15 Coffee break38

scientific program, Wednesday, 28 November 2007P-07-064P-07-065P-07-066P-07-067P-07-068P-07-069P-07-070Treatment of penile curvature withonly 1 or 2 plication suturesEmre Akkus, TurkeyB. Onal, H. Ozkara, B. Alici, H. Hattat,A. OnerPenile extender device in thetreatment of penile curvature dueto Peyronie‘s disease. results of aphase ii prospective studyNicola Mondaini, ItalyM. Di Marco, G. Giubilei, G. Pappgallo,P. GonteroPenile prosthesis insertion in acuteischaemic priapism: Long termfollow-upGiulio Garaffa, United KingdomP. Kumar, N. Christopher, D. RalphPatient satisfaction and surgeonexperience with the new AMS 700MS inflatable penile prosthesisDana Ohl, USAG. Henry, D. Culkin, S. Wilson, J. Delk,J. Otheguy, R. Shabsigh, L. D. KnollShort penis syndrome followingpenile prosthesis surgeryOmidreza Sedigh, ItalyM. Paradiso, F. LiberaleAugmentation phalloplasty: „Apicaland pericavernousal penile implant“Jamal Salhi, ItalyM. Del PreteSurgical treatment of congenitalglans tiltWojciech Perdzynski, PolandM. AdamekC-07 Instructional Course11.15 - 12.45 Room 3How to implant a penile prosthesisChairperson: Carlo Bettocchi, ItalyC-07-01C-07-02C-07-03C-07-04Closing CeremonyCounseling, consent and follow-upAmanda Spillings, United KingdomSelecting prosthesis and surgicaltricksDavid Ralph, United KingdomLong-term results and new techniquesIgnacio Moncada, SpainComplications – What should I do?Carlo Bettocchi, Italy12.45 - 13.15 Auditorium I39

poster presentationsMonday, 26 November -Wednesday, 28 November 2007The poster exhibition will be located in Pavilion 5 onthe first floor and in Room 3 on the ground floor ofthe Lisboa Congress Center. It is open to all conferencedelegates on:Monday, 26 November 2007 09.00 h - 17.00 hTuesday, 27 November 2007 09.00 h - 17.00 hWednesday, 28 November 2007 09.00 h - 13.00 hAll moderated posters will be located in Room 3where the moderated poster sessions will take place.The unmoderated posters will be displayed in Pavilion5 of the congress venue during the whole conference.They will be arranged according to topics and will benumbered within the topics.Interested participants can meet the authors for discussionof their posters during following times:Monday, 26 November 2007Tuesday, 27 November 200716.00 h - 16.30 h16.00 h - 16.30 hPP-01Basic SciencePoster PresentationsPP-01-146 Nitric oxide inhibition inducespenile vascular hyperreactivity viaendothelin up-regulationMichael Adams, CanadaJ. Banting, K. Manabe, J. Heaton,R. ShamloulPP-01-147PP-01-148PP-01-149The rat corpus spongiosum pressure(CSP) telemetry model and itsapplicationDebbie Baxter, United KingdomD. Reynolds, N. EdmundsThe effect of testosterone therapyon bladder functions and histologyin surgically menopause inducedratsSelahittin Cayan, TurkeyM. Tek, E. Balli, I. Oguz, S. KarazindiyanogluThe effect of the administration ofsildenafil citrate on a daily basis onthe histology of the mouse testis,epididymis, vas deference and penisFotis Dimitriadis, GreeceI. Vakalopoulos (Presenter)PP-01-150 Effects of diet control andphosphodiesterase type 5 inhibitoron endothelial function in hypercholesterol-dietratKweon Min, Republic of KoreaD. Kang, J. Park, H. Kim, S. ChoiPP-01-151PP-01-152PP-01-153PP-01-154PP-01-155PP-01-156Assessment of the use of sildenafilcitrate for the protection of erectiletissue and function followingcastration in the rat modelAlexander Müller, SwitzerlandS. Deveci, K. Kobylarz, R. Tal, T. Sulser,J. MulhallThe impact of shock wave therapyat varied energy and dose levels onfunctional and structural changesin erectile tissueAlexander Müller, SwitzerlandY. Akin-Olugbade, S. Deveci, J. Donohue,R. Tal, T. Sulser, J. MulhallUroflowmetry as reliable test indetection of neurogenic erectiledysfunction in diabetic patientsDjordje Nale, SerbiaAntenatal corticotherapy influencesadult male sexual behaviorMario Oliveira, PortugalP. Leao, N. SousaTransmission electron microscopycomparative study between normalhuman corpus cavernosum and aninduced male hypogonadism modelRui Oliveira, PortugalN. Tomada, I. Tomada, D. Neves,P. VendeiraCan penile blood be a marker topredict the erectile capacity?Ege Can Serefoglu, TurkeyH. Erdamar, A. T. Ozdemir, A. F. Atmaca,M. Berktas, M. D. Balbay40

poster presentationsPP-01-157The effect of testosterone replacementtherapy on bladder functionsand histology in late onsethypogonadism induced rat modelMesut Tek, TurkeyE. Balli, B. Cimen, O. Efesoy, S. CayanPP-02-164 Intermediate hyperglycemia inmetabolic syndrome predict therisk of precocious onset of erectiledysfunction in type 2 diabetesVasile Coca, RomaniaD. Porav, M. C. Coca, N. HancuPP-01-158Preliminary study of angiogenicfactors expression in corpuscavernosum in rat after chronicintake of high-fat dietInes Tomada, PortugalN. Tomada, R. Oliveira, P. Vendeira,D. NevesPP-01-159 Preparation of penile corporacavernosous matrix in rabbitsHui Zhu, People‘s Republic of ChinaH. Li, Y. Cui, Y. Gui, Z. CaiPP-02Risk factorsPP-02-160PP-02-161Poster PresentationsSexual and reproductive functionsin epileptic malesMohamed Abdallah, EgyptErectile function in patients whounderwent prostate saturationbiopsy: Comparision of prostatecancer patients and normalsCem Akbal, TurkeyP. Türker, H. H. Tavukçu, F. Simsek,L. TürkeriPP-02-162 The effect of consanguineousmarriage on male sexual functionCem Akbal, TurkeyH. H. Tavukçu, I. Tinay, N. Mangir, F.SimsekPP-02-163Circadian autonomic changes inpatients with and without erectiledysfunctionTolga Dogru, TurkeyM. Basar, E. Yuvanc, T. Celik, A. IyisoyPP-02-165PP-02-166PP-02-167PP-02-168PP-02-169PP-02-170Risk factors associated with erectiledysfunction among hemodialysispatientsOmer Demir, TurkeyA. Cihan, M. Secil, A. Celik, T. Demir,A. Comlekci, A. EsenEvaluation of the population ofmen with erectile dysfunction inPoland. Risk factors of erectiledysfunctionAndrzej Depko, PolandT. Leonowicz, Z. Raj, Z. Wieczerzak,A. JurgielewiczThe impact of migraine on femalesexual functionSerkan Deveci, TurkeyB. Horasanli, C. Celikkol, S. Benli,L. PeskirciogluEvaluation of incontinence, qualityof life and sexual function womenwho operated suburethral slingDilek Sari, TurkeyV. Bulut, O. Cakmak, O. Mertoglu,H. Sycramaz, A. Bolukbasi, A. EsenAssociated risk factors for erectiledysfunction in male diabeticpatientsSimona Fica, RomaniaN. Calomfirescu, O. Georgescu, M.Ursache, A. Reghina, S. Florea, M.GrigorescuPsychological variables and sexualfunctioning: Differences betweena clinical and a non-clinical groupregarding cognitive schemas andpersonality variablesAna Gomes, PortugalP. Nobre41

poster presentationsPP-02-171Erectile function alterations in mentreated with androgen suppressionplus radiation therapy for local orlocally advanced prostate cancerAhmet Hakan Haliloglu, TurkeyO. Yaman, S. BaltaciPP-03-179Epidemiological evolution of a Portugueseclinical population withsexual dysfunctionJorge Cardoso, PortugalJ. Pacheco, A. Gaspar, G. Pedrosa,B. Ingles, E. Morbeck (Presenter)PP-02-172PP-02-173Cognitive and emotional factorsin female sexual dysfunction:Schemas and affectCatia Oliveira, PortugalP. NobreMetabolic syndrome – a cause forerectile dysfunctionGheorghe Nita, RomaniaC. Persu, S. Bancu, V. Cauni, P. GeavletePP-02-174 Graded association betweenvasculogenic erectile dysfunction,metabolic syndrome and aorticstiffnessKonstantinos Rokkas, GreeceC. Vlachopoulos, N. Ioakeimidis,A. Samentzas, P. Pietri, P. Xaplanteris,C. Fassoulakis, T. Askitis, C. StefanadisPP-02-175PP-03Interrelationships between erectiledysfunction and smoking inessential hypertensive patientsKonstantinos Rokkas, GreeceC. Vlachopoulos, N. Ioakeimidis,A. Bratsas, A. Samentzas, S. Leontis,C. Fassoulakis, T. Askitis, C. StefanadisPoster PresentationsEpidemiology and preventionPP-03-176PP-03-177Sexual life evaluation in urologicalmale patientsCatalin Belinski, RomaniaA. Manu Marin, M. Neamtu,C. Neicutescu, E. Vesa, N. CalomfirescuPhysiopathological mechanisms ofpriapism: Comparative analysis oftheir evolutionPierre Bondil, Francek. bouraoui, f. ozone, a. demey,f. adawi, x. TaccoenPP-03-180PP-03-181PP-03-182PP-03-183PP-03-184PP-03-185Testicular volume and nutritionalstate as predictive factors offertility for cancer patients treatedby chemotherapyEleftherios Chatzidarellis, GreeceE. Mazaris, K. Ioannidis, M. Chrisofos,C. Deliveliotis, K. SyrigosEvaluation of the population ofmen with erectile dysfunction inPoland. Sources of knowledgeabout sexualityAndrzej Depko, PolandT. Leonowicz, Z. Raj, Z. Wieczerzak,A. JurgielewiczEvaluation of the population ofmen with erectile dysfunction inPoland. Characteristics of treatmentmethods of erectile dysfunctionAndrzej Depko, PolandT. Leonowicz, Z. Raj, Z. Wieczerzak,A. JurgielewiczPrevalence of andrologic diseasein schoolboys: Our three yearsexperienceAntonio M. Granata, ItalyV. Cicalese, U. Maggio, G. Micheletti,L. Antonelli, A. Cicalese, P. SambroiaSexual education in conservativeculturesAmr Jad, Saudi ArabiaA. ObeidDiabetes related sexual dysfunctionsLasanth Malavige, United KingdomS. D. Jayaratne, S. Kathriarachchi,S. Sivayogan, D. Fernando, U. Samaraweeraarachchi,J. Levy42

poster presentationsPP-03-186PP-03-187Psychometric validation of theSpanish version of the agingmales’ symptoms scale (AMSS) in apopulation-based sampleManuel Mas, SpainEFA (ASESA) Study GroupPrevalence, bother and impact onquality of life of sexual problems,luts and incontinence: Results fromthe hospitalized and outpatients‘profiles and expectations study(HOPES)Kyriakos Moisidis, GreeceG. Salpigidis, K. Hatzimouratidis,A. Apostolidis, P. Kirana, D. HatzichristouPP-04DiagnosisPP-04-193PP-04-194Poster PresentationsRelationship between IIEF score,erection hardness score and beckdepression index in the evaluationof erectile dysfunctionAltug Tuncel, TurkeyA. Atan, D. Tuglu, O. Aydin, T. Sipal, M.BasarAssesment of female sexual life byinterview, clinical evaluation andFSFI, in postmenopausal womenDana Bucuras, RomaniaC. Bucuras, D. GrigorasPP-03-188 Evaluation of child offender‘ssexual behaviours in a sample ofincarcerated adult malesPedro Pechorro, PortugalR. Vieira, C. PoiaresPP-03-189Male sexual dysfunction – datafrom a database covering 2,928consequtive patients between1994-2007Juhana Piha, FinlandPP-03-190 Comparing treatment seekingbehavior of patients with sexualproblems - luts and/or incontinence:Results from the hospitalizedand outpatients‘ profiles andexpectations study (HOPES)Georgios Salpigidis, GreeceK. Moisidis, A. Apostolidis, K. Hatzimouratidis,P.-S. Kirana, D. HatzichristouPP-04-195Application of cardiac autonomousindices to the study of theneurogenic erectile dysfunction:First resultsBeatrice Cuzin, FranceE. Pereira de Souza Neto, P. Abry,P. Loiseau, C. Baude, J. Frutoso,C. Gharib, X. MartinPP-04-196 Self image in individuals withsexual dysfunctionsEusebie Zbranca, RomaniaI. Gotca, V. Mogos, C. Cristea,V. Mocanu, E. ZbrancaPP-04-197Is it important to evaluate sympatheticactivity during theintracavernous injection test?Zeki Hamsioglu, TurkeyI. Yalug, C. Duman, L. Ozkan, M. Culha,C. OzkurkcugilPP-03-191PP-03-192The Internet on-line urologicalconsultationsPeter Scheplev, RussiaV. ShaderkinaInitial survey for differences inerectile dysfunction between continuousambulatory peritonealdialysis and hemodialysis patientsin TaiwanWeikung Tsai, TaiwanP. Chiang, S. YangPP-04-198Assessing sexual function afterradical prostatectomy should bestandardizedKurt Lehmann, SwitzerlandM. Zahner, B. Mazzola, R. CasellaPP-04-199 Arterial brachial flow predictsthe best hemodynamic responseto chronic Tadalafil treatment inerectile dysfunctionMario Mancini, ItalyM. Guazzi, L. Vaccalluzzo, G. M. Colpi43

poster presentationsPP-04-200PP-04-201PP-04-203PP-04-204PP-04-205Is audio-visual sexual stimulationreally important in performing theLevitra-test?Evsey Mazo, RussiaS. Gamidov, V. IremashviliInfluence of A 5androstenediol declinein aging male. On bioavailabletestosterone calculationJean-Pierre Raynaud, FranceJ. Tichet, F. Bronsard, C. Born, F. Giton,J. FietClinically meaningful improvementon the quality of erection questionnairefor erectile dysfunctionVera Stecher, USAK. Hvidsten, M. Carlsson, T. Symonds,I. LevinsonSignificant improvement in thequality of erection questionnairein men with erectile dysfunctiontreated with sildenafil citrate50 mg or 100 mgVera Stecher, USAP. Stroberg, L.-J. TsengCorrelation between carotid andfemoral atherosclerotic burden andvasculogenic erectile dysfunctionAthanasios Tsokanis, GreeceC. Vlachopoulos, K. Rokkas,D. Tsekoura, N. Ioakeimidis, K. Aznaouridis,T. Askitis, C. StefanadisPP-04-206 The link between erectiledysfunction, metabolic syndromeand testosterone deficiency: Outcomeof data analyses of 771 EDpatientsAksam Yassin, GermanyF. SaadPP-05Poster PresentationsPharmacology / PharmacotherapyPP-05-207Recovery of systemic levels offibroblast growth factor in diabeticpatients after treatment withsildenafil for 3 monthsNuno Louro, PortugalB. Cuevas, J. M. La Fuente, P. Cuevas,V. Cavadas, I. Saenz de Tejada, J. AnguloPP-05-208 Comparison of treatment oferectile dysfunction with phosphodiesteraseTYPE 5 inhibitors andother modalitiesPonnambalam Chandrasekar, UnitedKingdomG. Krishnamurthy, V. Sundarajan, B. PotluriPP-05-209PP-05-210PP-05-211Recovery of erectile function andveno-occlussive dysfunction afterchronic sildenafil treatmentLevend Ozkan, TurkeyM. Culha, C. Ozkurkcugil, A. GokalpAlternate-day tadalafil in the managementof honeymoon impotenceHussein Ghanem, EgyptR. El DakhlySexual rehabilitation for cardiacpatients: the role of a specialistclinicGraham Jackson, United KingdomE. Waring, C. McLeod, E. McGing,A. CooperPP-05-212 Asthenia as cause of sexualdysfunction in married menEkaterina Kulchavenya, RussiaPP-05-213Emotional well-being in men usingflexible-dose versus 100-mg fixeddosesildenafil citrate for erectiledysfunctionJohn Mulhall, USAV. Stecher, L.-J. Tseng44

poster presentationsPP-05-214Evaluation of the efficacy andsafety of Zydena ® (Udenafil) inmales with erectile dysfunctionand hypertension who are takingantihypertensive agentsJae-Seung Paick, Republic of KoreaS. W. Kim, Y. K. Park, J. S. Hyun,N. C. Park, S. W. Lee, K. H. Moon,W. S. ChungPP-05-215 Factors influencing patientsatisfaction after 12 months tadalafiltreatment: Results from theDETECT studyPetros Perimenis, GreeceT. Roumeguere, H. Heidler, E. Roos,M. Belger, H. SchmittPP-05-216PP-05-217PP-05-218Pharmacokinetic study of a noveltestosterone-in-adhesive matrixpatch during the 48 hours ofapplication to hypogonadal menJean-Pierre Raynaud, FranceC. Aumonier, V. Gualano, D. Betea,A. Beckers, D. Stavros (Presenter)Response to first month tadalafiltreatment predicts 12 monthcontinuation in patients witherectile dysfunction : Results fromthe DETECT studyThierry Roumeguere, Belgiumb. verheyden, s. arver, a. bitton,t. eliasson, m. belger, h. schmittEffects of sildenafil on Sertoli cellsecretory functionNikolaos Sofikitis, GreeceN. Pardalidis, E. Grammeniatis,D. Giannakis, S. Gratsias, N. Giotitsas,S. Tsabalas, A. Gekas, P. Tsounapi,D. Baltogiannis, I. MiyagawaPP-05-219 Significant improvement inself esteem and relationshipquestionnaire scores in men witherectile dysfunction treated withSildenafil Citrate 50 mg or 100 mgVera Stecher, USAP. Stroberg, L.-J. TsengPP-05-220PP-05-221PP-05-222Treatment satisfaction in men usingflexible-dose versus 100-mg fixeddosesildenafil citrate for erectiledysfunctionVera Stecher, USAJ. Mulhall, L.-J. TsengSignificant Improvement in theerectile dysfunction inventory oftreatment satisfaction questionnairescore in men with erectiledysfunction treated with SildenafilCitrate 50 mg or 100 mgPeter Stroberg, SwedenV. Stecher, L.-J. TsengSignificant improvement in thesexual experience questionnairescore in men with erectile dysfunctiontreated with SildenafilCitrate 50 mg or 100 mgPeter Stroberg, SwedenV. Stecher, L.-J. TsengPP-05-223 Giving patients with erectiledysfunction (ED) the opportunityto try all three available PDE-5 inhibitors will result in betterlongterm treatment compliance -results of a two year follow-upPeter Stroberg, SwedenC. Ljunggren, K. Salomonsson, H.HedelinPP-05-224PP-06Does the long-acting PDE5 inhibitortadalafil have longer-lasting ormore severe side-effects than theshort-acting PDE5 inhibitors?Joby Taylor, United KingdomA. Storey, R. Walker, J. Cartledge,I. EardleyPoster PresentationsSurgery and Peyronie‘s diseasePP-06-225Distal hypospadias: Does it requiresurgical intervention?Robert Peters, United KingdomJ.C. Goddard, S. Tank, M. A. Khan45

poster presentationsPP-06-226Patient and partner satisfaction inpenile prosthesis implantationBilali Gümüs, TurkeyA. Sahin, O. Cakmak, O. Demir, E. Can,I. Celen, A. Bolukbasi, A. EsenPP-06-227 Penile abscess and urethrocutaneousfistula as complicationsof intracavernous injection: Diagnosisand treatmentAntonio Virgil Iconaru, RomaniaV. Voinescu, M. Muresan, A. H. Ateia,D. Hristea, S. PersuPP-06-228PP-06-229PP-06-230PP-06-231PP-06-232PP-06-233Congenital penile curvatureAristomenis Gekas, GreeceP. Kartsaklis, C. Konstantinidis, I.Palaiodimos, S. Andreadakis,Surgical characteristics of rupturearea in fractured penisDjordje Nale, SerbiaMechanism of urethral stricture ininsertion of an inflatable penileprosthesisJong Kwan Park, Republic of KoreaS. W. Lee, B. H. Park, J. H. Lim,W. S. Cui, J. S. ParkA case of Fournier’s gangrene withextensive loss of integumentarytissue: The necessity of multidisciplinaryintegration to obtainoptimal resultsGiandomenico Passavanti, ItalyV. Pizzuti, A. Bragaglia, M. Brauzzi,P. Tanasi, M. R. Pagni, E. Norgini,A. M. Aloisi, M. Carlucci, R. PaoliniPenile paraphinoma secondary toOmega 3 injectionMiriam Kreizman, IsraelR. Rub, H. Marazka, N. ErlichAnalysis of alternative technologiesin treatment of strictures of anteriorurethra using complex method ofcomparative assessmentPeter Scheplev, RussiaA. Plutnitsky, N. Garin, B. Gvasaliya,E. GameevaPP-06-234PP-06-235PP-06-236Soft prosthesis implant (10 mm)and relaxing albugineal incisionwith PELVICOL grafting for surgicaltherapy of Peyronie‘s disease:A 1-years follow-up and ourpreliminary experienceOmidreza Sedigh, ItalyM. Paradiso, M. E. Graziano, F. Liberale,G. Cucchiarale, U. FerrandoFracture of penis: Review, analysesand treatment outcomes of 26 casesAksam Yassin, GermanyA. Shamsodini, K. Prasad, A. El Fadil,M. El Malik, A. Yassin, A. Al AnsariOutcome and satisfaction ratesof three-piece penile prosthesisimplantation for treatment oferectile dysfunction: Single centerexperienceNuno Tomada, PortugalI. Lopes, P. Diniz, M. Guimaraes,P. VendeiraPP-06-237 Anatomical radical retropubicprostatectomy in patients with apreexisting three-piece inflatableprosthesisAlberto Briganti, ItalyF. Doha, A. Briganti, A. Gallina,A. Salonia, G. Zanni, U. Capitanio,E. Strada, G. Petralia, A. Sacca,P. Rigatti, F. MontorsiPP-06-238PP-06-239PP-06-240Surgical treatment of severe laPeyronie disease with Pelvicol ®graftPedro Bargao, PortugalUse of cephalic vein grafting inPeyronie‘s disease: An effectiveoption?Marco Bitelli, ItalyM. Pietrantuono, A. Maraone, M. Ranieri,F. Pietrantuono, A. Zucchi, M. Valitutti,G. Virgili, G. VespasianiDoes diabetes mellitus exaggeratethe clinical symptoms of Peyronie‘sdisease?Hyunjun Park, Republic of KoreaN. Park, C. Lee, C. Yoon, W. Chon46

poster presentationsPP-06-241Ourcomes of combined theraphy ofelectromotive drug administrationand colchine in peyronie diseaseMehmet Lütfü Tahmaz, TurkeyH. C. Irkilata, I. Yildrim S. Basal, M.DayancPP-06-242 Cavernous venous dysfunction,cause of erectile failure, in penilefibrosisRiccardo Vaccari, ItalyF. PezzoniPP-06-243PP-07HormonesP-07-245PP-07-246Dorsal Nesbit corporoplasty procedureand relaxing scrotoplasty forcomplex penoscrotal deformitycurvature after skin urethroplastyAhmad Shamsodini, QuatarA. Al Naimi, O. Sedigh, S. Said,A. Al AnsariPoster PresentationsHemochromatosis, a rare cause ofhypogonadism - clinical caseVitor Cavadas, PortugalR. Borges, P. Masso, F. Vila, L. Osorio,N. Louro, M. Silva-Ramos, L. F. Carvalho,F. MarcelEffect of hyperprolactinemia inmale patients consulting for sexualdysfunctionGiovanni Corona, ItalyE. Mannucci, A. D. Fisher, F. Lotti,V. Ricca, G. Balercia, L. Petrone,G. Forti, M. MaggiPP-07-247 Should hormone replacementmimic normal chronobiology?Claudia Mattern, SwitzerlandM. DiverPP-07-248Efficacy of long-term injectabletestosterone undecanoate in lateonset hypogonadism patients for54 weeks follow-upDu Geon Moon, Republic of KoreaJ. W. YuPP-07-249PP-07-250PP-07-251PP-07-252PP-07-253PP-07-254PP-07-255The efficacy and safety of longactinginjectable testosteroneundecanoate (Nebido) in late onsethypogonadism patients: A Koreanmulticenter prospective studyDu Geon Moon, Republic of KoreaJ. K. Park, K. S. Park, S. W. Kim,N. C. Park, J. S. Paik, J. T. Seo, T. Y. Ahn,D. Y. Yang, S. W. Lee, J. J. KimVariation of male serum estradiol(E) after administration of morphinecloridrate (MC)Giandomenico Passavanti, ItalyV. Pizzuti, A. Aloisi, M. Carlucci,A. Bragaglia, F. Mengoni, R. PaoliniComparative study of androgensserum levels in hypogonadal mentreated with transdermal or oralpreparations of testosteroneMichele Pujos-Gautraud, FranceM. Colle, A. Lemaire, F. Giton,J.-P. RaynaudEffects of oral versus transdermaltestosterone treatment in hypogonadalmen on SHBG, LH, FSH,and AMS scoresMichele Pujos-Gautraud, FranceM. Colle, A. Lemaire, J.-P. RaynaudEfficacy and safety of a newtestosterone-in-adhesive matrixpatch applied every two days forone year to hypogonadal menJean-Pierre Raynaud, FrancePharmacokinetic study of a noveltestosterone-in-adhesive matrixpatch during the 48 hours ofapplication to hypogonadal menJean-Pierre Raynaud, France“Aging male symptoms“ questionnairein normal and complainingmenJean-Pierre Raynaud, FranceP. Igigabel, C. Born, F. Giton, J. Fiet47

poster presentationsPP-07-256PP-07-257PP-07-258PP-07-259Enlargement of penis in patientswith hypogonadism. Complexapproach to the clinical practiceMikhail Sokolschik, RussiaR. Petrovich, S. Gagarina, Y. Vaziev, I.SadakovaAnalyzing „real time“ total s-testosteronetogether with the ADAMquestionnaire-A method to identifylate onset hypogonadism (LOH) inclinical practice?Peter Stroberg, SwedenC. Ljunggren, A. OdenDoes testicular volume alter undertestosterone therapy?Aksam Yassin, GermanyA. Haider, A. Shamsodini, F. Saad,S. AlkadiGender issues on sexual desire:implications from medical, psychologicaland dyadic adjustmentJoana Carvalho, PortugalP. NobrePP-07-260 Sexual functioning versus riskfactors of atherosclerosis andchanges in hormonal levels ofyoung menJolanta Slowikowska-Hilczer, PolandK. Kula, K. Marchlewska, E. Oszukowska,A. Guminska, S. Jastrzebska,E. Kramek, E. Zawadzka, R. Walczak-JedrzejowskaPP-08-263Is there a place for the externalvacuum device (VED) in thetreatment of post-radical prostatectomy(RRP) patients who failPDE5 inhibitors?Juza Chen, IsraelG. Keren-Paz, A. Greenstein, Y. Bar-Yosef, N. J. Mabjeesh, H. MatzkinPP-08-264 Simultaneous implantation ofinflatable penile prosthesis andbone anchored bulbourethral slingafter radical prostatectomyRui Pinto, PortugalM. Guimaraes, R. Oliveira, A. Silva,F. Cruz, P. DinisPP-08-265 Erectile dysfunction screening:First step on detecting other moresevere pathologyDaniel Porav-Hodade, RomaniaN. Crisan, B. Feciche, Z.-A. Mihaly,B. Jalaizadeh, B. Petrut, I. ComanPP-08-266Penile rehabilitation & recoveryof penile lenght following radicalprostatectomy: 6 years follow-upMatteo Paradiso, ItalyA. Abbona, O. Sedigh, M. E. Graziano,F. Liberale, P. Giovanni, U. FerrandoPP-08-267 Vardenafil improves erectilefunction and quality of life in menwith benign prostatic hyperplasia:A randomised, placebo-controlledstudyChristian Stief, GermanyH. Porst (Presenter), D. Neuser, M. Beneke,E. UlbrichPP-08Poster PresentationsED and ejaculatory disordersPP-08-261 Erectile dysfunction and Peyronie‘sdisease in patients withretroperitoenal fibrosisCem Akbal, TurkeyY. Tanidir, M. B. Özgen, F. SimsekPP-08-262 The impact of low dose-rateprostate brachytherapy on erectilefunction – a chronological process?Andreas Bannowsky, GermanyL. Bäurle, A. Loch, U. Paul, T. LochPP-08-268PP-08-269Early penile rehabilitation afterlaparoscopic and retropubic radicalprostatectomyMustafa Faruk Usta, TurkeyO. Celik, T. Erdogru, A. KolA case of treatment of lifelongejaculatory inadequacy in a manwith a mild learning disabilityLoukas Athanasiadis, GreeceK. Anastasia, M. Dimitrios, P. Stamatis,M. Magiria, G. Kaprinis48

poster presentationsPP-08-270PP-08-271PP-08-272PP-09The efficacy and safety of tamsulosin0.2mg/day on sexual function inBPH: A multicenter studyDu Geon Moon, Republic of KoreaS. W. Lee, K. H. Moon, T. Y. Ahn,W. S. Jeong, D. Y. Yang, J. J. KimThe epidemiology peculiarity ofthe premature ejaculation in theterritory of Latvia, generatingfactors and the medical treatmentpossibilitiesAnatolijs Pozarskis, LatviaJ. ErenpreissSexual counseling for patients withdysfunctional ejaculationSonya Vasto, ItalyE. Italiano, C. LanzaronePoster PresentationsPsychotherapy, desire and arousalPP-09-273Sexual life evaluation using FSFIquestionnaire in gynecological andurological female patientsCatalin Belinski, RomaniaE. Popa, M. Crisan, A. Manu Marin,E. Vesa, N. CalomfirescuPP-09-274 Spontaneous orgasm associatedwith yawning: An unusual sideeffect of antidepressant medicationGabriella Gyovai, HungaryC. HuszkaPP-09-275Sexual counselling in the elderlycoupleJohannes Bitzer, SwitzerlandJ. AlderPP-09-276 Profiles of patients seekingtreatment for non-consummationof marriage at a sexual concernsclinic in Singapore and theirresponse to treatmentBeng-Yeong Ng, SingaporePP-09-277“Innovative“ sexual practices inpatients with mental illnessGheorghe Nita, RomaniaG. Petrisor, N. Gheorghe, M. Razvan,G. BogdanPP-10Sexual diversityPP-10-278PP-10-279PP-10-280Poster PresentationsEffect of NuvaRing on womensexual health conditionIgor Gorpynchenko, UkraineO. Romashchenko, S. Melnikov, V. Bilogolovskaya,L. YaschenkoProlonged androgen applicationsafety evaluation in patients withfemale transsexualismArkady Vertkin, RussiaL. Rudenko, S. Kalinchenko, M. Uryadnova,Y. Ramazanova, Y. Polupanova,A. NaumovFournier‘s gangrene of genitalia:Our experienceMarco Bitelli, ItalyM. Pietrantuono, M. Ranieri, A. Maraone,F. Pietrantuono, A. Zucchi,G. Ranieri, G. Virgili, E. Finazzi Agro,G. VespasianiPP-10-281 Day surgery management ofvaricocele: Subinguinal microsurgicalvaricocelectomyMarco Bitelli, ItalyF. Forte, I. A. Parisi, M. Valitutti,G. Pagliarella, A. Zucchi, G. Vespasiani,G. VirgiliPP-10-282 Cancer and sexual problems:Awareness and skills among healthprofessionals of general hospital:Preliminary resultsPierre Bondil, FranceD. HaboldPP-10-283Intrafascial nerve sparing techniqueimproves the rate of erectilefunction recovery after retropubicradical prostatectomy, compared tostandard techniqueAlberto Briganti, ItalyA. Gallina, A. Salonia, F. Deho, G. Zanni,f. Pellucchi, T. Camerota, G. Petralia,A. Sacca, P. Rigatti, F. Montorsi49

poster presentationsPP-10-284Obesity and comorbidities do notaffect erectile function recoveryafter bilateral nerve sparing radicalprostatectomyAlberto Briganti, ItalyA. Gallina, A. Salonia, F. Deho,G. Zanni, U. Capitanio, M. Bianchi,C. Maccagnano, A. Sacca, P. Rigatti,F. MontorsiPP-11General issuesPP-11-292Poster PresentationsComparison of KTP laser photoselectiveprostate vaporization vs.TUR-P on erectile functionEmre Akkus, TurkeyH. Hattat, A. ErolPP-10-285 Physical impairment and gender -a desmasculinizing effectJorge Cardoso, PortugalPP-11-293From Dick to John Thomas: Crossculturalnomenclature for the penisDavid Edwards, United KingdomPP-10-286Management of ischemic penilegangrene: the role of prompt partialpenectomy and other treatmentoptionsIni Chiang, TaiwanS. Chang, J. HsiehPP-11-294Patient preference of provider‘sgender in obstetrics and gynaecologyin United KingdomChannamallikarjuna Swamy MallappaSaroja, United KingdomA. Makam (Presenter), G. EdwardsPP-10-287The state of knowledge and theapproach of sexual dysfunctions bygeneral practitioners in BelgiumHubert Claes, BelgiumT. Roumeguere, C. Schulman, H. vanPoppelPP-10-288 Myths and sexuality in latepregnancyPedro Conde, PortugalA. Queiros, P. AmbrosioPP-10-289PP-10-290PP-10-291The effect of PDE5 inhibitors onpenile rigidity parameters in theperiod without sexual stimulationOguz Ekmekcioglu, TurkeyF. Halis, A. Demirtas, M. Karacagil,A. GokceLower urinary tract symptoms affectcontinence but not erectile functionrecovery after bilateral nervesparing radical prostatectomyAlberto Briganti, ItalyA. Gallina, A. Salonia, F. Deho, G.Zanni, F. Sozzi, T. Camerota, E. Strada,N. Suardi, P. Rigatti, F. MontorsiPhase II prospective study to testthe “efficacy“ and tolerability ofa penile extender device in thetreatment of „short penis“Paolo Gontero, ItalyM. di Marco, G. Giubilei, G. Pappagallo,A. Tizzani, N. MondainiPP-11-295 Teenagers about themselves:A study on information aboutsexuality in teenagersEusebie Zbranca, RomaniaV. Mogos, C. Moldovan, I. GotcaPP-11-296 Anxiety performance in malesexual life: Contributing factorsEvangelia Nakopoulou, GreeceG. Salpiggidis, P. Kapoteli, F. Ferenidou,S. PapaharitouPP-11-297PP-11-299PP-11-300The effect of alpha blocker therapyin patients with lower urinarytract symptoms who have erectiledysfunction or notIsmail Ozdemir, TurkeyO. Bozkurt, O. Demir, G. Aslan, A. EsenPortuguese validation of femalesexual function indexPedro Pechorro, PortugalA. Diniz, S. Almeida, R. VieiraSexual satisfaction: Relation withsexual satisfaction and with sexualbehavioursPedro Pechorro, PortugalR. Vieira, A. Diniz50

poster presentationsPP-11-301PP-11-302Pregnancy and phimosisGeavlete Petrisor, RomaniaG. Nita (Presenter), M. Razvan, G. BogdanPenile fracture: Diagnosis, managementand outcome at twourological centersRui Pinto, PortugalM. Oliveira, R. Oliveira, J. Ribeiro,N. Tomada, P. Vendeira, A. Santos,F. CruzPP-11-303 Difference in sexual historyobtaining among doctorsMona Reda, EgyptPP-11-304 Sexual functions after renaltransplantation in malesAli Sahin, TurkeyA. Cihan, K. Akgul, O. Demir, A. Gurkan,A. Celik, E. Can, A. EsenPP-11-308PP-11-309PP-11-310Superselective embolization therapyof dominant side for arterial priapismdue to bilaterale cavernous arterylacerationMehmet Lütfü Tahmaz, TurkeyB. Üstünsöz, I. Yildirim, M. DayancGenitourinary reconstruction afterFornier’s GangreneMehmet Lütfü Tahmaz, TurkeyC. Irkilata, I. Yildirim, M. DayancAnalysis of the counterfeit erectiledysfunction drug (Levitra) found inPolandElzbieta Tajanko, PolandM. Wronka, B. Kozlowska-BoszkoPP-11-311 Sexual medicine in symbolicmotives of Anatolian kilimsHakan Taskapu, TurkeyO. Sanli, T. Akman, A. KadiogluPP-11-305PP-11-306PP-11-307Repeated end-to-end urethroplastyPeter Scheplev, RussiaB. Gvasaliya (Presenter), N. GarinHistory of andrology and sexualmedicine in Russia: Role ofprofessional societiesPeter Scheplev, RussiaN. Garin, B. GvasaliyaStrangulation of the penis by acone bearning as a result of malesexual competitivenessMartin Sutory, Czech RepublicT. Sramkova, J. DolezelPP-11-312PP-11-314Bilateral congenital absence ofthe vas deferens coexisting withbilateral seminal vesicle agenezisand solitary pelvic kidneyMehmet Umul, TurkeyB. Turna, B. Altay, O. NazliSexual complaints and life satisfactionin men and women withmultiple sclerosisBirgitta Hulter, Sweden51

List of exhibitorsBooth No. ExhibitorExhibitorsBooth No.1 Bayer Schering Pharma AG2 American Medical Systems EuropeB.V. – AMS3 Ipsen Pharma4 ProStrakan6 Nature Publishing Group7 Wisepress Ltd.9 ESDA10 ESSM11 Eli Lilly and Company12 Pfizer Inc.13 Coloplast A/S14 Ardana Bioscience Ltd.15 EFS16 Timm Medical Technologies, Inc.American Medical Systems EuropeB.V. – AMS 2Ardana Bioscience Ltd. 14Bayer Schering Pharma AG 1Coloplast A/S 13EFS 15ESDA 9ESSM 10Ipsen Pharma 3Eli Lilly and Company 11Nature Publishing Group 6Pfizer Inc. 12ProStrakan 4Timm Medical Technologies, Inc. 16Wisepress Ltd. 7Exhibition Plan - First Floor1613Poster ExhibitionPavillion 5347611 12Pavillion 41CateringArea14Catering159 10Auditoria andMeeting RoomsInternetCentre2Speakers Centreand Lounge52

List of chairpersons and presentersName Page Name PageAAbdallah, M. ................................................................... 41Abdo, C. ......................................................................... 37Abraham, L. .................................................................... 28Adams, M. ...................................................................... 40Ahn, B. ............................................................................ 33Akbal, C. ................................................................... 41, 48Akkus, E. ............................................................. 27, 39, 50Akman, T. .................................................................. 34, 38Alder, J. ........................................................................... 28Alsaid, B. ......................................................................... 34Althof, S. E. ..................................................................... 35Anderson, P. .................................................................... 22Angulo, J. ........................................................................ 31Appel, B. ......................................................................... 30Arver, S. .......................................................................... 26Athanasiadis, L. ......................................................... 32, 48Aversa, A. ........................................................................ 26BBannowsky, A. ........................................................... 31, 48Bargao, P. ........................................................................ 46Barnes, T. ........................................................................ 36Baxter, D. ........................................................................ 40Beck, J. ............................................................................ 24Becker, A. ........................................................................ 31Belinski, C. ................................................................ 42, 49Berner, M. ....................................................................... 38Bessede, T. ....................................................................... 32Bettocchi, C. .................................................................... 39Bianchi-Demicheli, F. ......................................................... 24Birowo, P. ........................................................................ 25Bitelli, M. ................................................................... 46, 49Bitzer, J. ..................................................................... 24, 49Bockting, W. .................................................................... 38Bondil, P. ....................................................... 30, 34, 42, 49Bonierbale, M. ................................................................. 38Bouloux, P.-M. ..................................................... 23, 29, 36Briganti, A. ........................................ 30, 31, 36, 46, 49, 50Brock, G. ......................................................................... 35Brucker, A. ...................................................................... 27Bucuras, D. ................................................................ 23, 43Buvat, J. .............................................................. 26, 29, 33CCanale, D. ....................................................................... 23Cardoso, J. ................................................................ 42, 50Caruso, S. ........................................................................ 29Carvalho, J. ..................................................................... 48Cavadas, V. ...................................................................... 47Cayan, S. ......................................................................... 40Chandrasekar, P. .............................................................. 44Chatzidarellis, E. .............................................................. 42Chen, J. ..................................................................... 24, 48Chevret-Measson, M. ................................................ 25, 36Chiang, I. ........................................................................ 50Chitale, S. ........................................................................ 23Cho, I. R. ................................................................... 23, 33Christ, G. ......................................................................... 30Claes, H. .......................................................................... 50Clayton, A. ...................................................................... 28Clement, P. ...................................................................... 33Coca, V. ..................................................................... 31, 41Colombo, F. ..................................................................... 37Columbo, F. ..................................................................... 22Conaglen, H. ................................................................... 25Conde, P. ......................................................................... 50Cordell, W. H. .................................................................. 27Corona, G. .............................................. 26, 27, 30, 37, 47Costa, C. ......................................................................... 31Culha, M. ........................................................................ 34Cuzin, B. ................................................................... 33, 43DDamsted-Petersen, C. ................................................ 25, 28Darewicz, B. .................................................................... 27Dean, J. ............................................. 22, 23, 30, 35, 36, 38de Boer, B. J. ................................................................... 29Demir, O. ............................................................. 26, 33, 41Dennerstein, L. ................................................................ 24Depko, A. .................................................................. 41, 42Deveci, S. ........................................................................ 41Dimitriadis, F. ................................................................... 40Dogru, T. ......................................................................... 41EEardley, I. ................................................. 23, 29, 30, 35, 37Edwards, D. ............................................................... 30, 50Ekmekcioglu, O. .............................................................. 50Elzevier, H. W. .................................................................. 24FFaix, A. ...................................................................... 22, 37Fica, S. ............................................................................. 41Filippi, S. .......................................................................... 27Fugl-Meyer, A. ................................................................. 25Fusco, F. .......................................................................... 29GGamidov, S. ..................................................................... 32Garaffa, G. .......................................................... 22, 34, 39Gckert, S. .................................................................. 24, 26GGmGs, B. ...................................................................... 46Ghanem, H. ..................................................................... 44Giraldi, A. .................................................................. 23, 30Giuliano, F. .......................................................... 27, 28, 33Goddard, J. C. ................................................................. 45Goldmeier, D. .................................................................. 25Goldstein, I. ............................................................... 22, 25Gomes, A. ....................................................................... 41Gontero, P. ...................................................................... 50Gorin, A. ......................................................................... 38Gorpynchenko, I. ............................................................. 49Granata, A. M. ................................................................ 42Gruenwald, I. ............................................................ 28, 30Guiliano, F. ...................................................................... 22Gutierrez, P. ..................................................................... 24Gvasaliya, B. .................................................................... 51Gyovai, G. ....................................................................... 4953

list of chairpersons and presentersName Page Name PageHHackett, G. ................................................................ 26, 36Haliloglu, A. H. ................................................................ 42Hamsioglu, Z. .................................................................. 43Hannan, J. ....................................................................... 26Hattat, I. .......................................................................... 38Hatzichristou, D. ........................................................ 23, 33Hedlund, P. ................................................................ 23, 35Hulter, B. ......................................................................... 51IIconaru, A. V. ................................................................... 46Ioakeimidis, N. ........................................................... 26, 31JJackson, G. .......................................................... 26, 33, 44Jad, A. ............................................................................. 42Jannini, E. .................................................................. 25, 38Juenemann, K.-P. ............................................................. 25Justo, D. .......................................................................... 30KKadioglu, A. .............................................................. 22, 34Kartsaklis, P. .............................................................. 34, 46Kim, J. J. .......................................................................... 36Kim, S.-O. ........................................................................ 29Kirby, M. ......................................................................... 25Kocsis, A. ........................................................................ 28Kreizman, M. ................................................................... 46Kulchavenya, E. ............................................................... 44Kun, A. ............................................................................ 28Kurbatov, D. .................................................................... 34Kurtz, L. .......................................................................... 24LLaan, E. T. ........................................................................ 23Lazar, D. .......................................................................... 24Leaker, B. ........................................................................ 33Lee, S. W. ........................................................................ 31Lehmann, K. .................................................................... 43Lemaire, A. ...................................................................... 37Levin, R. .................................................................... 25, 28Lew-Starowicz, M. ........................................................... 37Louro, N. ......................................................................... 44MMaggi, M. ................................................................. 22, 26Makam, A. ...................................................................... 50Malavige, L. ..................................................................... 42Mallappa Saroja, C. S. ..................................................... 50Mancini, M. ..................................................................... 43Markovic, D. .................................................................... 32Martin-Morales, A. .................................................... 30, 34Martinez-Salamanca, J. I. ................................................. 38Mas, M. ..................................................................... 26, 43Mazo, E. .......................................................................... 44McMahon, C. ............................................................ 28, 38McVary, K. T. ................................................................... 35Meryn, S. ......................................................................... 35Meuleman, E. .................................................................. 23MGller, A. ............................................................ 27, 32, 40Michetti, P. M. ................................................................. 37Min, K. ............................................................................ 40Mirone, V. ....................................................................... 30Modi, N. B. ...................................................................... 37Moisidis, K. ...................................................................... 43Moncada, I. ................................................... 22, 37, 38, 39Mondaini, N. ................................................................... 39Monteiro Pereira, N. .................................................. 32, 33Montorsi, F. ......................................................... 23, 25, 36Montorsi, P. ..................................................................... 35Moon, D. G. .............................................................. 47, 49Morbeck, E. ..................................................................... 42Morelli, A. ........................................................... 23, 26, 28Morgan, F. ....................................................................... 35Mulhall, J. ............................................................ 25, 27, 44NNakopoulou, E. ................................................................ 50Nale, D. ..................................................................... 40, 46Nappi, R. ......................................................................... 32Ng, B.-Y. .......................................................................... 49Nita, G. ............................................................... 42, 49, 51Nobre, P. .......................................................................... 30OOger-Roussel, S. .............................................................. 28Ohl, D. ............................................................................ 39Oliveira, C. ...................................................................... 42Oliveira, M. ...................................................................... 40Oliveira, R. ....................................................................... 40Ortigue, S. ....................................................................... 28Ozdemir, I. ....................................................................... 50Ozkan, L. ......................................................................... 44PPacheco Palha, A. J. ......................................................... 30Pahin, A. F. ...................................................................... 37Paick, J.-S. ................................................................. 35, 45Papaharitou, S. .......................................................... 24, 38Paradiso, M. .................................................................... 48Park, H. ........................................................................... 46Park, J. K. ........................................................................ 46Pascoal, P. ........................................................................ 31Passavanti, G. ............................................................ 46, 47Pe‘er-Arazy, I. .................................................................. 30Pechorro, P. ......................................................... 37, 43, 50Peeters, M. ...................................................................... 27Perdzynski, W. ................................................................. 39Perimenis, P. .................................................................... 45Perovic, S. .................................................................. 22, 34Pescatori, E. S. ........................................................... 33, 38Petrisor, G. ...................................................................... 51Piha, J. ............................................................................. 43Pili, M. ............................................................................. 33Pinto, R. .................................................................... 48, 51Porav-Hodade, D. ............................................................ 48Porst, H ........................................................................... 22Porst, H. .............................................................. 32, 35, 48Pozarskis, A. .................................................................... 49Pozzato, C. ...................................................................... 33Prieto, D. ......................................................................... 37Pujos-Gautraud, M. ......................................................... 4754

list of chairpersons and presentersName Page Name PageQQueiros, A. ...................................................................... 24RRadopoulos, D. ................................................................ 34Ralph, D. ............................................................. 22, 37, 39Raynaud, J.-P. .......................................... 32, 36, 44, 45, 47Reda, M. ................................................................... 37, 51Rehder, P. ........................................................................ 34Rivas, D. .......................................................................... 37Rokkas, K. ................................................................. 31, 42Rosen, R. C. ..................................................................... 29Rossello, M. ..................................................................... 35Roumeguere, T. ......................................................... 33, 45Rubio-Aurioles, E. ...................................................... 27, 37SSahin, A. ................................................................... 24, 51Salhi, J. ............................................................................ 39Salonia, A. ....................................................................... 30Salpigidis, G. ................................................................... 43Sanchez, A. ..................................................................... 27Sansalone, S. ................................................................... 22Sari, D. ............................................................................ 41Scheplev, P. .............................................. 34, 38, 43, 46, 51Schjoerring, O. ................................................................ 31Schulman, C. ............................................................. 22, 35Schultheiss, D. ................................................................. 32Seal, L. ............................................................................ 24Sedigh, O. ........................................................... 34, 39, 46Serefoglu, E. C. ............................................................... 40Shamsodini, A. ................................................................ 47Sharlip, I. ................................................................... 22, 23Shaw, J. ........................................................................... 27Shin, H.-Y. ....................................................................... 26Simonelli, C. .................................................................... 36Simonsen, U. ................................................................... 31Slowikowska-Hilczer, J. .................................................... 48Sofikitis, N. ...................................................................... 45Sohn, M. ................................................................... 32, 38Sokolschik, M. ................................................................. 48Spillings, A. ..................................................................... 39Stanojevic, D. ............................................................ 34, 38Stecher, V. ................................................................. 44, 45Stief, C. 48Stroberg, P. .......................................................... 33, 45, 48Suh, J.-K. ......................................................................... 26Summerton, D. ................................................................ 22Sungur, M. ...................................................................... 36Sutory, M. ....................................................................... 51TTahmaz, M. L. ............................................................ 47, 51Tajanko, E. ....................................................................... 51Talseth, T. ........................................................................ 38Taskapu, H. ...................................................................... 51Taylor, J. .......................................................................... 45Tek, M. ............................................................................ 41Terry, T. ............................................................................ 22Tinel, H. .......................................................................... 25Todorova, M. ................................................................... 23Tomada, I. ....................................................................... 41Tomada, N. ................................................................ 34, 46Tomelini, M. .................................................................... 24Tsai, W. ............................................................................ 43Tsokanis, A. ..................................................................... 44Tuncel, A. ........................................................................ 43UUgolini, V. ........................................................................ 38Umul, M. ................................................................... 32, 51Usta, M. F. ....................................................................... 48VVaccari, R. ....................................................................... 47Vakalopoulos, I. ............................................................... 31van Lunsen, R. ........................................................... 28, 29van Wingen, G. ............................................................... 29Vardi, Y. ........................................................................... 28Vasto, S. .......................................................................... 49Vendeira, P. ..................................................................... 33Vertkin, A. ....................................................................... 49Vieira, R. ......................................................................... 24Vlachopoulos, C. ................................................. 26, 31, 37WWaldinger, M. D. ........................................... 25, 28, 33, 38Waldkirch, E. ............................................................. 27, 37Weidner, W. .................................................................... 30Wylie, K. .......................................................................... 38Wyllie, M. G. ................................................................... 38YYassin, A. ...................................................... 37, 44, 46, 48ZZahariou, A. .................................................................... 25Zbranca, E. ................................................................ 43, 50Zhu, H. ............................................................................ 41Zucchi, A. ........................................................................ 34Zumbe, J. ........................................................................ 3655

Joint Congressof the European andInternational Societiesfor Sexual Medicine7-11 December 2008Brussels Expo - Brussels - Belgiumwww.issmessm2008.info13th World Congressof the International Societyfor Sexual Medicine11th Meetingof the European Societyfor Sexual Medicine

For men with ED• CIALIS works fast, as early as 16-minutes1• CIALIS lasts long, for up to 36 hours*CIALIS (TADALAFIL) ABBREVIATED PRESCRIBING INFORMATIONFor oral use. CIALIS is available as 2.5, 5, 10, and 20 mg film-coated tablets.Use in adult menIn general, the recommended dose is 10 mg taken prior to anticipated sexual activity and with or without food.In those patients in whom tadalafil 10 mg does not produce an adequate effect, 20 mg might be tried. It may be taken at least 30 minutes prior to sexual activity.The maximum dose frequency is once per day.Tadalafil 10 and 20 mg is intended for use prior to anticipated sexual activity and it is not recommended for continuous daily use.In responder patients to on-demand regimen who anticipate a frequent use of CIALIS (i.e., at least twice weekly) a once daily regimen with the lowest doses ofCIALIS might be considered suitable, based on patient choice and the physician’s judgement.In these patients the recommended dose is 5 mg taken once-a-day at approximately the same time of day. The dose may be decreased to 2.5 mg once-a-day basedon individual tolerability.The appropriateness of continued use of the daily regimen should be reassessed periodically.Use in elderly menDose adjustments are not required in elderly patients.Use in men with impaired renal functionDose adjustments are not required in patients with mild to moderate renal impairment. For patients with severe renal impairment 10 mg is the maximumrecommended dose. Once-a-day dosing of tadalafil is not recommended in patients with severe renal impairment.(See sections 4.4 and 5.2).Use in men with impaired hepatic functionThe recommended dose of CIALIS is 10 mg taken prior to anticipated sexual activity and with or without food. There is limited clinical data on the safetyof CIALIS in patients with severe hepatic impairment (Child-Pugh Class C); if prescribed, a careful individual benefit/risk evaluation should be undertaken bythe prescribing physician. There are no available data about the administration of doses higher than 10 mg of tadalafil to patients with hepatic impairment.Once-a-day dosing has not been evaluated in patients with hepatic impairment; therefore, if prescribed, a careful individual benefit/risk evaluation should beundertaken by the prescribing physician. (See section 5.2).Use in men with diabetesDose adjustments are not required in diabetic patients.Use in children and adolescentsCIALIS should not be used in individuals below 18 years of age.A full updated SPC is available at the booth upon request.Reference 1. Cialis SPC.* CIALIS ® is a registered trademark of Eli Lilly and Company.Up to 36 hours of efficacy*

Congress andExhibition OfficeCPO HANSER SERVICEHanser & Co GmbHZum Ehrenhain 3422882 Barsbüttel • GermanyTelephone: +49 40 670 88 20Fax: +49 40 670 32 83E-Mail: essm@cpo-hanser.de